Clinical Trials - AMGN

NCT IDTitleStatusPhasesStart DateCompletion DatePrimary Completion Date
NCT07134088A Study of Subcutaneous Blinatumomab in Children With R/R and and MRD+ B-Cell Precursor Acute Lymphoblastic LeukemiaNOT_YET_RECRUITINGPHASE1, PHASE22025-11-212030-06-182028-12-05
NCT07213674A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate CancerNOT_YET_RECRUITINGPHASE32025-11-012032-08-302028-08-29
NCT07172919A Rollover Study Evaluating Sotorasib With or Without Panitumumab in Participants With KRAS p.G12C MutationNOT_YET_RECRUITINGPHASE22025-10-202027-10-202027-10-20
NCT07140900Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate CancerRECRUITINGPHASE12025-10-072030-03-302028-03-27
NCT07037758A Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311)RECRUITINGPHASE12025-09-162031-01-042028-03-04
NCT06987539A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)NOT_YET_RECRUITINGPHASE22025-08-292030-01-042030-01-04
NCT07142642A Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Teprotumumab (AMG 632) Administered Intravenously in Healthy Chinese ParticipantsACTIVE_NOT_RECRUITINGPHASE12025-08-262025-11-222025-11-22
NCT07136012OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular EventsRECRUITINGPHASE32025-08-222031-03-192031-03-19
NCT07005128A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)RECRUITINGPHASE32025-08-182029-07-152029-01-04
NCT07160257A Study to Evaluate the Effect of Maridebart Cafraglutide on Insulin Sensitivity and β-cell Function in Participants With Type 2 Diabetes MellitusRECRUITINGPHASE12025-08-052026-12-132026-08-26
NCT07094113AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid TumorsRECRUITINGPHASE12025-07-312030-09-092027-09-06
NCT07037433Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or ObesityRECRUITINGPHASE32025-07-252030-09-292028-06-30
NCT06570798A Phase 2a Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune DiseasesRECRUITINGPHASE22025-07-162029-06-232028-09-15
NCT07037459Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and ObesityRECRUITINGPHASE32025-06-252030-09-292028-06-30
NCT06987695Efficacy and Safety of Maridebart Cafraglutide in Adult Participants in Japan Who Have Obesity DiseaseRECRUITINGPHASE32025-06-132027-10-192027-07-26
NCT06588153A Study for the Evaluation of Efficacy and Safety of Prolia® in Participants With Glucocorticoid-induced Osteoporosis in Mainland ChinaRECRUITINGPHASE42025-05-242027-05-242027-05-24
NCT06898957Study of Tarlatamab in Combination With YL201 With or Without Anti-programmed Death Ligand 1 (PD-L1) in Participants With Extensive Stage (ES) Small Cell Lung Cancer (SCLC)RECRUITINGPHASE12025-05-162031-05-212031-05-21
NCT06910709Single and Multiple Ascending Dose Study of AMG 378 in Healthy ParticipantsRECRUITINGPHASE12025-04-082028-10-042028-10-04
NCT06858878Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are OverweightACTIVE_NOT_RECRUITINGPHASE32025-03-172027-04-252027-01-30
NCT06858839Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are OverweightACTIVE_NOT_RECRUITINGPHASE32025-03-122027-04-272027-02-01
NCT06745323A Phase 2, Open-label, Randomized, Multicenter Study of Tarlatamab Dosing Regimens in Subjects With SCLCRECRUITINGPHASE22025-02-262029-02-132029-02-13
NCT06747949A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)RECRUITINGPHASE32025-02-252029-08-262029-08-26
NCT06700343Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)RECRUITINGPHASE32025-01-132027-12-172027-01-15
NCT06649006Study to Investigate Intravenous Blinatumomab in Japanese Adult Participants With Newly Diagnosed Philadelphia-negative B-precursor Acute Lymphoblastic Leukemia (B-ALL)ACTIVE_NOT_RECRUITINGPHASE12025-01-082025-12-152025-07-30
NCT06593522A Phase 2 Study of AMG 193 in Participants With MTAP-deleted Advanced NSCLC (MTAPESTRY 201)RECRUITINGPHASE22024-12-262029-09-112027-09-12
NCT06691984Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute)RECRUITINGPHASE32024-12-092029-07-302028-12-01
NCT06613100Evaluation of Neoadjuvant Xaluritamig in Localized Prostate CancerRECRUITINGPHASE12024-11-252030-01-232026-09-19
NCT06660173A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM)ACTIVE_NOT_RECRUITINGPHASE22024-11-072026-06-252025-10-09
NCT06321601Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV.RECRUITINGPHASE32024-10-222030-07-202030-07-20
NCT06637371A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate AsthmaRECRUITINGPHASE12024-10-162026-10-252026-09-13
NCT06411860A Study to Assess the Effect of Olpasiran on QT/QTc Intervals in Healthy ParticipantsCOMPLETEDPHASE12024-10-102024-12-112024-11-29
NCT06598306Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)RECRUITINGPHASE12024-10-072030-03-272027-02-01
NCT06555796Evaluation of Xaluritamig in High-Risk, Biochemically Recurrent, Non-metastatic Castrate-sensitive Prostate CancerRECRUITINGPHASE12024-09-232029-06-212026-12-21
NCT06333951AMG 193 Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol) (MTAPESTRY 104).RECRUITINGPHASE12024-09-172031-10-272028-10-27
NCT06430866Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab)RECRUITINGPHASE32024-09-122027-03-152026-03-27
NCT06311721A Study to Compare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung CancerRECRUITINGPHASE32024-09-092028-05-292028-02-14
NCT06585462Single and Multiple Ascending Dose Study of AMG 513 in Participants With ObesityRECRUITINGPHASE12024-09-092026-07-222026-07-22
NCT06502977Study Evaluating Tarlatamab in Chinese Participants With Advanced Small Cell Lung Cancer After Two or More Prior Lines of TreatmentACTIVE_NOT_RECRUITINGPHASE22024-08-272026-05-112025-03-28
NCT06976372A Study to Evaluate AMG 133 Administered Subcutaneously in Participants With Overweight or ObesityCOMPLETEDPHASE12024-08-202024-12-272024-12-27
NCT06332014Evaluation of Efficacy and Safety of Prolia in Subjects of Male Osteoporosis in Mainland ChinaRECRUITINGPHASE42024-08-062027-03-312027-03-31
NCT06438263A Study to Evaluate Bioavailability of Rocatinlimab Autoinjector and Vial in Healthy ParticipantsCOMPLETEDPHASE12024-08-062025-05-032025-05-03
NCT06054113Study of Blinatumomab Administration in Chinese Pediatric Participants With Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)RECRUITINGPHASE22024-07-232027-12-242026-03-04
NCT06527404A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab in Prurigo NodularisRECRUITINGPHASE32024-07-182027-05-142027-02-22
NCT06252649Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C MutationRECRUITINGPHASE32024-07-172031-08-312028-01-31
NCT06061523A Clinical Trial to Evaluate Bioavailability and Effect of Food for Sotorasib in Healthy ParticipantsWITHDRAWNPHASE12024-07-152024-09-092024-09-09
NCT06468826A Study of Avacopan in Participants With Normal Renal Function and Participants With End-Stage Renal Disease (ESRD)COMPLETEDPHASE12024-07-112024-10-052024-10-05
NCT06248619A Trial to Investigate Teprotumumab Subcutaneous Administration Compared With Placebo in Male and Female Adult Participants With Moderate-to-severe Active Thyroid Eye DiseaseACTIVE_NOT_RECRUITINGPHASE32024-07-052026-09-292026-02-10
NCT06211036Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and DurvalumabRECRUITINGPHASE32024-06-052028-10-142027-07-05
NCT06401044A Study of AMG 732 in Healthy Participants and Participants With Thyroid Eye DiseaseRECRUITINGPHASE12024-05-302027-08-132027-02-22
NCT06360354A Study Evaluating AMG 193 in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion (MTAPESTRY 103)RECRUITINGPHASE12024-05-292029-02-252027-02-26
NCT06376045A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe AsthmaRECRUITINGPHASE22024-05-242026-10-022026-08-10
NCT06312020A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjogren's SyndromeRECRUITINGPHASE22024-05-092027-02-092026-06-02
NCT06352892A Study to Evaluate AMG 133 in Chinese Participants With Obesity or OverweightCOMPLETEDPHASE12024-04-252024-08-272024-08-27
NCT05972551Study to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in Children and Adolescents With Osteogenesis ImperfectaRECRUITINGPHASE32024-04-222027-08-252027-06-01
NCT06245408A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom StateRECRUITINGPHASE32024-04-082026-11-032026-09-02
NCT06224192A Study With Self-administered Rocatinlimab in Adolescent and Adult Participants With Moderate-to-severe Atopic DermatitisACTIVE_NOT_RECRUITINGPHASE32024-04-022026-03-152025-04-11
NCT06180278Long-term, Open-label, Safety Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorder (NMOSD)ACTIVE_NOT_RECRUITINGPHASE42024-04-022028-06-262028-06-26
NCT06229145A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared With Every 2 Weeks (Q2W) With MTX in Participants With Uncontrolled Refractory GoutACTIVE_NOT_RECRUITINGPHASE42024-03-182026-04-092025-07-30
NCT06131398A Study of AMG 355 Alone and in Combination With Pembrolizumab in Participants With Advanced Solid TumorsRECRUITINGPHASE12024-03-072028-12-222028-03-02
NCT06117774Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)RECRUITINGPHASE32024-02-202030-03-312030-03-31
NCT06268860A Study to Assess Bioavailability of Rocatinlimab (AMG 451) Vial and Prefilled Syringe in Healthy ParticipantsCOMPLETEDPHASE12024-02-152024-08-302024-08-30
NCT06072482A Study to Evaluate Avacopan in Participants With ANCA-associated VasculitisRECRUITINGPHASE42024-02-072036-12-312036-12-31
NCT06104124A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease ActivityACTIVE_NOT_RECRUITINGPHASE32024-01-242026-08-192026-06-18
NCT06214481A Study to Evaluate Rocatinlimab (AMG 451) in Healthy Chinese ParticipantsCOMPLETEDPHASE12024-01-232024-05-272024-05-27
NCT05669014A Phase 2 Proof of Concept Study to Evaluate the Efficacy and Safety of Daxdilimab in Participants With Dermatomyositis (DM) or Anti-synthetase Inflammatory Myositis (ASIM)COMPLETEDPHASE22023-12-042025-07-022025-07-02
NCT06122649A Study to Investigate Efficacy and Safety of Apremilast 30 mg Twice Daily (BID) in Chinese Participants With Moderate to Severe Plaque-type Psoriasis (PsO)ACTIVE_NOT_RECRUITINGPHASE32023-11-272025-12-072025-02-28
NCT05920356A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)RECRUITINGPHASE32023-11-162031-06-302026-06-30
NCT06054555A Study to Evaluate ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Unresectable or Metastatic MelanomaRECRUITINGPHASE32023-11-022027-01-252027-01-25
NCT06079476A Study of Romosozumab (EVENITY®) in Postmenopausal Women in India With Osteoporosis at a High Risk of Fracture.ACTIVE_NOT_RECRUITINGPHASE42023-10-302025-10-212025-10-21
NCT06088199A Study of Apremilast in Pediatric Participants in Children With Mild to Moderate Plaque PsoriasisRECRUITINGPHASE32023-10-242026-07-062026-07-06
NCT05323617Efficacy of Romiplostim in Treatment of SAA in Adults Previously Untreated With or Refractory to Immunosuppressive TherapyWITHDRAWNPHASE22023-08-312025-02-252025-02-25
NCT04998747A Study of Subcutaneous (SC) AMG 701 in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)WITHDRAWNPHASE12023-08-292025-08-282025-08-02
NCT04586660Study of XGEVA® (Denosumab) in Chinese Adults and Skeletally Mature Adolescents With Giant Cell Tumor of the BoneACTIVE_NOT_RECRUITINGPHASE42023-08-172028-03-072028-03-07
NCT05975073A Phase 1/2 Study of AMG 193 in Combination With IDE397 in Participants With Advanced Methylthioadenosine Phosphorylase (MTAP)-Null Solid TumorsACTIVE_NOT_RECRUITINGPHASE1, PHASE22023-08-012026-01-052026-01-05
NCT05907122A Study to Evaluate Similarity of ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Resected MelanomaACTIVE_NOT_RECRUITINGPHASE32023-07-262025-11-302025-10-04
NCT05549258Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum DisorderRECRUITINGPHASE22023-07-032027-04-132027-04-13
NCT05800964Study to Explore the Safety, Tolerability, and Pharmacokinetics of AMG 305 in Subjects With Advanced Solid TumorsRECRUITINGPHASE12023-06-132028-02-122027-06-10
NCT05899816A Study Assessing Rocatinlimab on Vaccine Antibody Response in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET - VOYAGER)COMPLETEDPHASE32023-06-072024-11-142024-08-26
NCT05891119Study to Investigate the Effect of Rocatinlimab (AMG 451) on the Pharmacokinetics of Multiple Cytochrome P450 (CYP450) Substrates in Participants With Moderate to Severe Atopic DermatitisCOMPLETEDEARLY_PHASE12023-06-032024-12-262024-08-21
NCT05882877A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)ACTIVE_NOT_RECRUITINGPHASE32023-05-312027-06-022027-06-02
NCT05740566Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung CancerACTIVE_NOT_RECRUITINGPHASE32023-05-312028-03-262025-01-29
NCT05672199Long-term Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative ColitisTERMINATEDPHASE22023-04-282024-10-312024-10-31
NCT05540665Study of Daxdilimab (HZN-7734) in Participants With Active Proliferative Lupus Nephritis (LN)TERMINATEDPHASE22023-04-262024-01-042024-01-04
NCT05704738A Study to Evaluate Rocatinlimab (AMG 451) in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)ACTIVE_NOT_RECRUITINGPHASE32023-04-202025-11-272025-09-08
NCT06674941A Trial to Investigate Teprotumumab (High-concentration Formulation) Subcutaneous Administration in Healthy Adult Non-Japanese and Japanese ParticipantsCOMPLETEDPHASE12023-03-242023-11-142023-11-14
NCT05767047A Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic ArthritisRECRUITINGPHASE32023-03-232036-03-172036-03-17
NCT03904069Study Evaluating the Safety, Tolerability, and Efficacy of FLT3 CAR-T AMG 553 in FLT3-positive Relapsed/Refractory AMLWITHDRAWNPHASE12023-03-132030-08-072030-08-07
NCT05317078A Phase 1 Safety, Tolerability, and Pharmacokinetics Study of AMG 794 With Claudin 6-positive Non-small Cell Lung Cancer, Epithelial Ovarian Cancer, and Other Malignant Solid Tumor IndicationsTERMINATEDPHASE12023-02-282024-04-012023-12-19
NCT05724199A Study Assessing Rocatinlimab in Combination With Topical Corticosteroid and/or Topical Calcineurin Inhibitors in Adult Participants With Moderate-to-severe Atopic Dermatitis (AD)COMPLETEDPHASE32023-02-212024-12-042024-09-15
NCT05633355A Study to Assess the Safety, Tolerability, and Efficacy of Rocatinlimab in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)COMPLETEDPHASE32023-01-302025-07-312025-07-31
NCT05565560A Study to Assess the Efficacy and Safety of Apremilast in Japanese Pediatric Participants With Moderate to Severe Plaque PsoriasisACTIVE_NOT_RECRUITINGPHASE32023-01-252026-09-062025-11-25
NCT05704725A Study to Evaluate ABP 938 and Aflibercept (Eylea®) in Participants With Chorioretinal Vascular Disease (CVD)COMPLETEDPHASE32023-01-232023-03-242023-02-17
NCT05669599Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Subjects With Overweight or Obesity, With or Without Type 2 Diabetes MellitusACTIVE_NOT_RECRUITINGPHASE22023-01-182026-01-022024-10-08
NCT05591222Study of Daxdilimab (HZN-7734) in Participants With Moderate-to-Severe Primary Discoid Lupus ErythematosusTERMINATEDPHASE22022-12-292025-05-082025-05-08
NCT05581303Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes TrialACTIVE_NOT_RECRUITINGPHASE32022-12-142026-12-292026-12-29
NCT05651711A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon)COMPLETEDPHASE32022-12-142024-08-272024-06-05
NCT05209152AMG 176 With Azacitidine in Subjects With Myelodysplastic Syndrome /Chronic Myelomonocytic LeukemiaTERMINATEDPHASE12022-11-142023-12-192023-12-19
NCT04781543A Multicenter Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients With Diffuse Cutaneous Systemic SclerosisTERMINATEDPHASE22022-11-042025-02-242025-02-24
NCT05626751An Open-label Extension Trial of HZNP-HZN-825-301 in Adult Participants With Diffuse Cutaneous Systemic Sclerosis (Diffuse Cutaneous SSc)TERMINATEDPHASE22022-11-042025-02-242025-02-24
NCT05284747EVOLVE-MI: EVOLocumab Very Early After Myocardial InfarctionACTIVE_NOT_RECRUITINGPHASE42022-10-262027-05-292027-05-29
NCT05325866A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) OverexpressionACTIVE_NOT_RECRUITINGPHASE1, PHASE22022-09-232026-02-062026-02-06
NCT05481411A Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Olpasiran in Participants With Various Degrees of Hepatic ImpairmentCOMPLETEDPHASE12022-09-132023-05-312023-04-05
NCT05489614A Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Olpasiran in Participants With Normal Renal Function and Participants With Various Degrees of Renal ImpairmentCOMPLETEDPHASE12022-09-132023-12-192023-10-24
NCT05361395First-Line Tarlatamab in Combination With Carboplatin, Etoposide, and PD-L1 Inhibitor in Subjects With Extensive Stage Small Cell Lung Cancer (ES-SCLC)ACTIVE_NOT_RECRUITINGPHASE12022-08-242028-08-282028-08-28
NCT05406115Single and Multiple Ascending Dose Study to Evaluate AMG 786 in Healthy Participants and Participants With ObesityCOMPLETEDPHASE12022-07-262023-08-212023-08-21
NCT06389578A Study of TEPEZZA® Treatment in Participants With Thyroid Eye DiseaseCOMPLETEDPHASE12022-07-142023-09-122023-02-28
NCT05497557A Study to Evaluate the Impact of Omeprazole on the Pharmacokinetics of Sotorasib Co-administered With an Acidic Beverage in Healthy VolunteersCOMPLETEDPHASE12022-07-142022-09-082022-09-08
NCT06207682Effect of Repeated Oral Doses of Avacopan on the Pharmacokinetics (PK) of a Single Dose of SimvastatinCOMPLETEDPHASE12022-06-282022-08-112022-08-11
NCT05430854Study of Daxdilimab (HZN-7734) for the Treatment of Systemic Lupus Erythematosus in an Open-label Extension StudyTERMINATEDPHASE22022-06-012023-10-312023-10-31
NCT05398445A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE)COMPLETEDPHASE32022-05-312025-01-132024-11-28
NCT05322577A Study Evaluating Bemarituzumab in Combination With Other Anti-cancer Therapies in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer.ACTIVE_NOT_RECRUITINGPHASE1, PHASE22022-05-172028-03-122026-01-15
NCT05368103Study of DAXDILIMAB for the Treatment of Moderate-to-Severe Alopecia AreataCOMPLETEDPHASE22022-04-272024-01-262023-08-07
NCT05198934Sotorasib and Panitumumab Versus Investigator's Choice for Participants With Kirsten Rat Sarcoma (KRAS) p.G12C MutationACTIVE_NOT_RECRUITINGPHASE32022-04-192025-12-312025-07-16
NCT05378529A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD)COMPLETEDNA2022-04-192023-12-302023-12-30
NCT05267470A Study of Bemarituzumab Monotherapy and Combination With Other Anti-cancer Therapy in SqNSCLC With FGFR2b Overexpression (FORTITUDE-201)TERMINATEDPHASE12022-03-292024-05-282024-05-28
NCT05327491A Study in Healthy Volunteers to Compare the Pharmacokinetics of Sotorasib Administered as 1 or 2 TabletsCOMPLETEDPHASE12022-03-212022-07-172022-07-17
NCT04804553Apremilast Pediatric Study in Children With Active Juvenile Psoriatic ArthritisRECRUITINGPHASE32022-03-172028-12-292028-03-21
NCT05111626Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer.ACTIVE_NOT_RECRUITINGPHASE32022-03-142027-01-292026-01-29
NCT05174065Phase 3, Randomized Study of Apremilast in Japanese Participants With Palmoplantar Pustulosis (PPP)COMPLETEDPHASE32022-03-082024-06-012023-08-19
NCT05052801Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) OverexpressionACTIVE_NOT_RECRUITINGPHASE32022-03-072026-06-202025-06-20
NCT05094336A Study of AMG 193 in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101)RECRUITINGPHASE1, PHASE22022-02-012028-11-272026-12-30
NCT04987307Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative ColitisTERMINATEDPHASE22022-01-312024-10-222024-10-22
NCT04933695A Study of Sotorasib (AMG 510) in Participants With Stage IV NSCLC Whose Tumors Harbor a KRAS p.G12C Mutation in Need of First-line TreatmentCOMPLETEDPHASE22022-01-282025-05-272025-05-27
NCT05060016A Phase 2 Study of Tarlatamab in Patients With Small Cell Lung Cancer (SCLC)ACTIVE_NOT_RECRUITINGPHASE22021-12-012027-04-302026-04-30
NCT04478994A Study With TEPEZZA in Patients With Diffuse Cutaneous Systemic Sclerosis (dcSSc)TERMINATEDPHASE12021-11-172022-12-082022-11-29
NCT04994717Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic LeukemiaRECRUITINGPHASE32021-11-022031-09-302027-06-24
NCT05073315A Comparative Study Between ABP 501 and Humira® in Participants With Moderate to Severe Plaque PsoriasisCOMPLETEDPHASE32021-10-042022-12-192022-12-19
NCT04885998AMG 757 and AMG 404 in Subjects With Small Cell Lung Cancer (SCLC)COMPLETEDPHASE12021-09-272024-09-112023-07-12
NCT05002998TEPEZZA® (Teprotumumab-trbw) Post-Marketing Requirement StudyACTIVE_NOT_RECRUITINGPHASE42021-09-162026-01-052026-01-05
NCT05056246Study of AMG 133 Administered Subcutaneously in Healthy Japanese and Caucasian ParticipantsCOMPLETEDPHASE12021-09-102022-04-082022-04-08
NCT04528082Apremilast Pediatric Study in Children With Active Oral Ulcers Associated With Behçet's DiseaseRECRUITINGPHASE32021-09-092030-12-172030-02-07
NCT04583735A Study Evaluating TEPEZZA® Treatment in Patients With Chronic (Inactive) Thyroid Eye DiseaseCOMPLETEDPHASE42021-09-022023-10-122023-03-17
NCT04822298Study of AMG 160 in Subjects With Non-Small Cell Lung CancerTERMINATEDPHASE12021-08-312022-01-262021-12-08
NCT04506086Feasibility Study to Evaluate Outpatient Blinatumomab in Subjects With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL)TERMINATEDPHASE42021-08-262024-09-162024-07-04
NCT05032066A Multicenter Trial to Evaluate the Efficacy, Safety and Tolerability of HZN-825 in Subjects With Idiopathic Pulmonary FibrosisTERMINATEDPHASE22021-08-252025-01-022024-07-22
NCT05045638Effect of Coadministration of Sotorasib on the Pharmacokinetics of Rosuvastatin in Healthy ParticipantsCOMPLETEDPHASE12021-08-202021-10-102021-10-10
NCT05048784A Study to Compare the Pharmacokinetics of Two Different Tablets of Sotorasib in Healthy ParticipantsCOMPLETEDPHASE12021-08-162022-02-182022-02-18
NCT04987333Study of Efavaleukin Alfa in Healthy Chinese, Japanese, and Caucasian ParticipantsCOMPLETEDPHASE12021-08-092022-10-032022-10-03
NCT04987320A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Olpasiran in Chinese Participants With Elevated Serum Lipoprotein(a)COMPLETEDPHASE12021-07-282022-03-182021-11-12
NCT05909852A Study Comparing the Pharmacokinetics (PK) of ABP 501 40 mg/0.4 mL (ABP 501-HCF) and ABP 501 40 mg/0.8 ml (ABP 501-LCF) in Healthy Adult ParticipantsCOMPLETEDPHASE12021-07-232021-11-242021-11-24
NCT04948099A Study of Single and Multiple Ascending Doses of VIB1116 in Rheumatic DiseasesCOMPLETEDPHASE12021-07-062023-07-032023-07-03
NCT04825678A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With MigraineCOMPLETEDPHASE42021-06-112023-09-282023-09-28
NCT04702737A Study of AMG 757 in Participants With Neuroendocrine Prostate CancerCOMPLETEDPHASE12021-06-102024-07-222024-07-22
NCT04925934Study of VIB7734 for the Treatment of Moderate to Severely Active SLECOMPLETEDPHASE22021-05-282023-06-092023-05-16
NCT04857606Single Ascending Dose of AMG 609 in Participants With Non-alcoholic Fatty Liver DiseaseCOMPLETEDPHASE12021-05-242023-07-192023-07-19
NCT04466917A Study of ABP 215 Versus Bevacizumab in Chinese Subjects With Advanced Non-Squamous Non-Small Cell Lung CancerWITHDRAWNPHASE32021-05-152022-11-132022-11-13
NCT04680637Efficacy and Safety of Efavaleukin Alfa in Subjects With Active Systemic Lupus ErythematosusTERMINATEDPHASE22021-05-062023-05-222023-05-22
NCT04740034A Study of AMG 340 in Subjects With Metastatic Castrate-Resistant Prostate CarcinomaTERMINATEDPHASE12021-04-292024-06-242024-06-24
NCT04727554Study of AMG 994 Monotherapy and AMG 994 and AMG 404 Combination Therapy in Participants With Advanced Solid TumorsCOMPLETEDPHASE12021-04-292023-06-052023-06-05
NCT04887064Pharmacokinetics of Sotorasib in Healthy Participants and Participants With Moderate or Severe Hepatic ImpairmentCOMPLETEDPHASE12021-04-222022-03-092022-03-09
NCT04833855Study to Evaluate Tezepelumab in Adults With Chronic Spontaneous UrticariaCOMPLETEDPHASE22021-04-152023-04-132022-12-20
NCT04761627A Study to Investigate Interchangeability of ABP 654 for the Treatment of Participants With Moderate to Severe Plaque PsoriasisCOMPLETEDPHASE32021-03-242023-02-282023-02-28
NCT04772313Pegloticase and Methotrexate Co-administered in Participants With Uncontrolled Gout Who Previously Failed Pegloticase MonotherapyCOMPLETEDPHASE42021-03-082023-04-242022-08-23
NCT04762498A Phase 4, Open-label Study of KRYSTEXXA® (Pegloticase) Co-administered With Methotrexate (MTX) in Patients With Uncontrolled Gout (FORWARD OL)COMPLETEDPHASE42021-01-262023-12-202023-05-18
NCT04545554Study to Evaluate Romosozumab in Children and Adolescents With Osteogenesis ImperfectaCOMPLETEDPHASE12021-01-212023-03-302023-03-30
NCT04631601Safety and Efficacy of Therapies for Metastatic Castration-resistant Prostate Cancer (mCRPC)TERMINATEDPHASE1, PHASE22021-01-152023-10-232023-10-23
NCT04521231A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALLRECRUITINGPHASE1, PHASE22021-01-042029-05-252027-12-24
NCT04540497A Study of Inebilizumab Efficacy and Safety in IgG4- Related DiseaseACTIVE_NOT_RECRUITINGPHASE32020-12-042028-10-312024-04-09
NCT04590586Study of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized PatientsCOMPLETEDPHASE32020-11-242021-08-032021-08-03
NCT04607980A Study to Investigate ABP 654 for the Treatment of Participants With Moderate to Severe Plaque PsoriasisCOMPLETEDPHASE32020-11-112022-06-032022-01-13
NCT04265755Biomarker and Genetic Predictors of Erenumab Treatment ResponseCOMPLETEDPHASE42020-10-262023-01-182023-01-18
NCT04524273Myasthenia Gravis Inebilizumab TrialACTIVE_NOT_RECRUITINGPHASE32020-10-152027-11-292024-05-28
NCT04511702Infusion Duration Study To Assess Tolerability of Pegloticase Administered With a Shorter Infusion Duration in Subjects With Uncontrolled Gout Receiving MethotrexateCOMPLETEDPHASE42020-10-022024-03-252024-01-18
NCT04524455Blinatumomab in Combination With AMG 404 for the Treatment of Adults With Relapsed or Refractory B Cell Precursor ALLCOMPLETEDPHASE12020-10-022023-01-242023-01-24
NCT04478695Study of AMG 330 in Combination With Pembrolizumab in Adult With Relapsed or Refractory Acute Myeloid LeukemiaTERMINATEDPHASE12020-09-292020-10-232020-10-23
NCT06563856A Study of TEPEZZA Subcutaneous Administration in Healthy AdultsCOMPLETEDPHASE12020-09-222021-05-272021-05-27
NCT04362748Study of AMG 256 in Adult Subjects With Advanced Solid TumorsCOMPLETEDPHASE12020-09-152023-09-212023-09-21
NCT04252742Erenumab - Comprehensive Assessment of Efficacy in (High-Frequency) Episodic MigraineCOMPLETEDPHASE42020-09-152023-10-262023-10-26
NCT04478708Single and Multiple Ascending Dose Study of AMG 133 in Participants With ObesityCOMPLETEDPHASE12020-08-072022-11-182022-11-18
NCT04191616Study of Early Relapsed, Lenalidomide-refractory Subjects Eligible for Carfilzomib TripletCOMPLETEDPHASE22020-08-062024-10-012022-11-30
NCT04270760Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction - DOSE Finding StudyCOMPLETEDPHASE22020-07-282022-11-082021-12-27
NCT05599828A Study to Evaluate the Impact of Acid-reducing Agents on the Pharmacokinetics (PK) of AMG 510 in Healthy ParticipantsCOMPLETEDPHASE12020-07-172020-09-132020-09-13
NCT04260191Study of AMG 910 in Subjects With CLDN18.2-Positive Gastric and Gastroesophageal Junction AdenocarcinomaTERMINATEDPHASE12020-06-292022-06-022022-06-02
NCT04270747A Study to Understand Effectiveness and Safety of ABP 938 Compared to Aflibercept (Eylea®) in Patients Suffering With Neovascular Age-related Macular Degeneration [Neovascular (Wet) AMD]COMPLETEDPHASE32020-06-222023-01-302022-07-18
NCT04303780Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200).ACTIVE_NOT_RECRUITINGPHASE32020-06-042026-02-252022-08-02
NCT04380753AMG 510 Ethnic Sensitivity Study (CodeBreaK 105).ACTIVE_NOT_RECRUITINGPHASE12020-04-282026-06-162021-12-31
NCT05578859A Study of the Absorption, Metabolism, and Excretion of [14C]-AMG 510 Following a Single Oral Dose in Healthy Male SubjectsCOMPLETEDPHASE12020-03-112020-03-242020-03-24
NCT04292275Heart Failure Study to Evaluate Vital Signs and Overcome Low Use of Guideline-Directed Therapy by Remote MonitoringTERMINATEDNA2020-03-062021-10-012021-10-01
NCT05571163A Study to Evaluate the Relative Bioavailability of AMG 510 Administered as Tablets and as a Water Dispersion in Healthy ParticipantsCOMPLETEDPHASE12020-03-062020-06-142020-06-14
NCT04221542Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate CancerRECRUITINGPHASE12020-03-042032-03-042030-03-05
NCT03937154Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast CancerRECRUITINGPHASE32020-02-262027-05-202026-05-20
NCT04058028Efficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE)COMPLETEDPHASE22020-02-192023-07-252023-07-25
NCT04068181Talimogene Laherparepvec With Pembrolizumab in Melanoma Following Progression on Prior Anti-PD-1 Based Therapy (MASTERKEY-115) (Mk-3475-A07/KEYNOTE-A07).COMPLETEDPHASE22020-01-222024-02-262021-08-19
NCT04117958Study of AMG 199 in Subjects With MUC17-Positive Solid Tumors Including Gastric, Gastroesophageal Junction, Colorectal, and Pancreatic CancersTERMINATEDPHASE12020-01-202023-06-012023-06-01
NCT05581992Study to Evaluate the Drug-drug Interaction Effect of Omeprazole on the Pharmacokinetics (PK) of AMG 510 in Healthy ParticipantsCOMPLETEDPHASE12020-01-062020-01-262020-01-26
NCT04174677Safety and Tolerability of Inebilizumab, VIB4920, or the Combination in Highly Sensitized Candidates Awaiting Kidney Transplantation From a Deceased DonorWITHDRAWNPHASE22019-12-272022-042021-12
NCT04175613A Long-term Extension Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque PsoriasisACTIVE_NOT_RECRUITINGPHASE32019-12-202025-12-162025-10-21
NCT03969329A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving HemodialysisRECRUITINGPHASE32019-12-202027-06-302027-06-30
NCT04185883Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)RECRUITINGPHASE12019-12-172027-12-052026-06-16
NCT04199351Single and Multiple Ascending Dose Study of AMG 171 in Subjects With ObesityTERMINATEDPHASE12019-12-132021-09-102021-09-10
NCT04129164A Study to Evaluate the Efficacy and Safety of VIB4920 in Participants With Sjögren's SyndromeCOMPLETEDPHASE22019-12-092023-03-102022-09-01
NCT04163991A Study to Evaluate the Safety and Efficacy of VIB4920 in Participants With Rheumatoid ArthritisCOMPLETEDPHASE22019-12-092021-12-282021-12-28
NCT03912337Effect of Erenumab-aooe on Disability and Work Productivity in Employed Subjects With Episodic MigraineTERMINATEDPHASE42019-12-042021-07-282021-07-28
NCT05568082A Study to Evaluate the Drug-drug Interaction Effect of Itraconazole on the Pharmacokinetics (PK) of AMG 510 in Healthy ParticipantsCOMPLETEDPHASE12019-12-032019-12-172019-12-17
NCT05581758A Study to Assess the Effect of Food on the Pharmacokinetics (PK) of AMG 510 in Healthy ParticipantsCOMPLETEDPHASE12019-11-142019-12-092019-11-25
NCT05550129Study to Evaluate the Drug-drug Interactions Between Metformin and AMG 510 in Healthy ParticipantsCOMPLETEDPHASE12019-11-132019-11-252019-11-25
NCT05988034A Study to Assess the Effect of Avacopan at Therapeutic and Supratherapeutic Doses on the QT/QTc Interval in Healthy ParticipantsCOMPLETEDPHASE12019-11-082020-03-312020-01-22
NCT05598281Study to Evaluate the Effect of AMG 510 on the Pharmacokinetics (PK) of Digoxin in Healthy ParticipantsCOMPLETEDPHASE12019-11-052019-11-192019-11-19
NCT05577624A Study to Evaluate the Drug-drug Interaction Effect of Rifampin on the Pharmacokinetics of AMG 510 in Healthy ParticipantsCOMPLETEDPHASE12019-11-052019-12-012019-12-01
NCT04046549A Study to Evaluate the Safety and Efficacy of Dual Costimulation Blockade With VIB4920 and Belatacept for Prophylaxis of Allograft Rejection in Adults Receiving a Kidney TransplantCOMPLETEDPHASE22019-10-302023-03-222022-07-18
NCT04057937A Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Japanese Subjects With Palmoplantar PustulosisCOMPLETEDPHASE22019-10-162021-06-072021-01-18
NCT03971071A Study to Evaluate the Efficacy and Safety of Erenumab in Adults With Medication Overuse HeadacheCOMPLETEDPHASE42019-10-072023-06-132022-12-01
NCT03362177Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal CancerCOMPLETEDPHASE32019-09-302025-01-092024-01-25
NCT03934684Study to Evaluate Safety Tolerability & Efficacy of Kyprolis (Carfilzomib) in Relapsed or Refractory Multiple MyelomaCOMPLETEDPHASE42019-09-162025-06-272023-03-23
NCT04087720Study of Pegloticase in Participants With Uncontrolled Gout Who Have Had a Kidney TransplantCOMPLETEDPHASE42019-09-092021-09-072021-07-06
NCT03832998Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic MigraineACTIVE_NOT_RECRUITINGPHASE32019-09-052026-01-092025-01-08
NCT04139226A Study to Evaluate the Safety, Tolerability Pharmacokinetics, and Pharmacodynamics of a New Spray Dried Dispersion (SDD) Formulation of CC-11050 After Single Dose of CC-11050 and to Evaluate the Pharmacokinetics of CC-11050 Under Fasted and Fed Conditions and After Coadministration With OmeprazoleCOMPLETEDPHASE12019-08-282020-02-272020-02-27
NCT03836040Efficacy and Safety of Erenumab in Pediatric Participants With Episodic MigraineACTIVE_NOT_RECRUITINGPHASE32019-07-192026-10-132025-11-19
NCT03930186A Phase 3B, Open-label, Single-arm Study of the Efficacy and Safety of Apremilast, in Subjects With Plaque Psoriasis That is Not Adequately Controlled by Topical TherapyCOMPLETEDPHASE32019-06-172020-09-252020-05-08
NCT03994731Study of KRYSTEXXA® (Pegloticase) Plus Methotrexate in Participants With Uncontrolled GoutCOMPLETEDPHASE42019-06-132022-04-112021-03-17
NCT03872401Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or StrokeCOMPLETEDPHASE32019-06-112025-07-252025-07-25
NCT03927144Study of Sustained Benefit of AMG334 in Adult Episodic Migraine PatientsCOMPLETEDPHASE42019-05-152022-09-302021-10-01
NCT03433755Safety and Efficacy of Evolocumab in Addition to Optimal Stable Background Statin Therapy in Chinese Participants With Primary Hypercholesterolemia and Mixed DyslipidemiaTERMINATEDPHASE32019-05-092020-05-092020-04-24
NCT03859427A Study Comparing Once-weekly vs Twice-weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple MyelomaCOMPLETEDPHASE32019-05-082023-03-312023-03-31
NCT03633708A Study of Etelcalcetide in Pediatric Subjects With Secondary Hyperparathyroidism and Chronic Kidney Disease on HemodialysisRECRUITINGPHASE32019-04-292029-01-312029-01-31
NCT03812224A Controlled Trial of Erenumab in Migraine PreventionCOMPLETEDPHASE32019-04-122020-11-252020-03-16
NCT03774875A Study of the Impact of Apremilast (CC-10004) on Quality of Life, Efficacy, and Safety in Adults With Manifestations of Plaque Psoriasis and Impaired Quality of LifeCOMPLETEDPHASE42019-03-282021-11-032021-02-01
NCT03809663A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic DermatitisTERMINATEDPHASE22019-03-152020-12-222020-05-12
NCT03721172Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and EfficacyCOMPLETEDPHASE32019-03-112020-07-242020-03-06
NCT03853109AMG 404 in Patients With Advanced Solid TumorsCOMPLETEDPHASE12019-03-052023-11-022022-07-19
NCT03836053Assessment of AMG 420 in Subjects With Relapsed and/or Refractory Multiple MyelomaTERMINATEDPHASE12019-03-042022-04-212022-04-21
NCT03777436An Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate to Severe Genital PsoriasisCOMPLETEDPHASE32019-02-112022-02-092021-09-23
NCT03783026A Study to Evaluate the Impact of Apremilast on Magnetic Resonance Imaging (MRI) Outcomes in Adults With Psoriatic ArthritisCOMPLETEDPHASE42019-02-062022-05-112021-10-26
NCT03792841Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPCTERMINATEDPHASE12019-02-052023-06-292023-06-29
NCT05885451A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of AMG 592 in Healthy Japanese ParticipantsCOMPLETEDPHASE12019-01-292019-04-112019-04-11
NCT03818607A Study Evaluating the Efficacy and Safety of ABP 959 Compared With Eculizumab in Adult Participants With PNHCOMPLETEDPHASE32019-01-222022-07-122022-07-12
NCT03747939Efficacy, Safety, and Tolerability Study of Apremilast to Treat Early Oligoarticular Psoriatic Arthritis.COMPLETEDPHASE42018-12-312023-07-052022-12-19
NCT03852472Evaluation of Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa (AURORA)COMPLETEDPHASE22018-12-212021-03-092021-01-14
NCT03701763Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque PsoriasisCOMPLETEDPHASE32018-12-192023-03-272022-04-25
NCT03817424A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and DermatomyositisCOMPLETEDPHASE12018-12-132020-07-202020-07-20
NCT03757130Multiple Ascending Dose Study of AMG 598 in Adults With ObesityCOMPLETEDPHASE12018-11-262019-12-162019-12-16
NCT03570697Imaging of Coronary Plaques in Participants Treated With EvolocumabCOMPLETEDPHASE32018-11-192021-01-212020-12-18
NCT03619187An Interventional Study to Evaluate the Effect of Ivabradine on Exercise Capacity in Heart Transplant RecipientsWITHDRAWNPHASE32018-11-022020-02-192020-02-19
NCT03571828Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 562 in Subjects With r/r Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, or Follicular LymphomaTERMINATEDPHASE12018-10-292022-01-122022-01-12
NCT03703908A Study of CCX140-B in Subjects With Primary FSGS and Nephrotic SyndromeTERMINATEDPHASE22018-10-012020-06-242020-06-24
NCT03635957Study of Pegloticase (KRYSTEXXA®) Plus Methotrexate in Patients With Uncontrolled GoutCOMPLETEDPHASE42018-09-262020-10-262019-10-23
NCT03541369Safety, Tolerability, PK, PD, and Efficacy of AMG 427 in Subjects With Relapsed/Refractory Acute Myeloid LeukemiaTERMINATEDPHASE12018-09-142023-02-212023-02-21
NCT03392064A Phase 1 Study Evaluating the Safety, Tolerability and Efficacy of AMG 119 in Subjects With RR SCLCSUSPENDEDPHASE12018-09-102027-01-142027-01-14
NCT03600883A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100)ACTIVE_NOT_RECRUITINGPHASE1, PHASE22018-08-272026-01-312026-01-31
NCT03465540Safety, Tolerability, Pharmacokinetics and Efficacy of AMG 397 in Subjects With Selected Relapsed or Refractory Hematological MalignanciesTERMINATEDPHASE12018-08-172019-07-252019-07-25
NCT03621605A Phase1 Study of VIB9600TERMINATEDPHASE12018-08-142019-04-082019-04-08
NCT03403374Safety and Tolerability of Repatha® (Evolocumab) in Indian Participants With Homozygous Familial HypercholesterolemiaCOMPLETEDPHASE42018-08-042019-11-272019-11-27
NCT03626662Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of AMG 890 in Subjects With Elevated Plasma Lipoprotein(a)COMPLETEDPHASE12018-07-302023-04-182023-04-18
NCT03638128Open-label Extension of Study 20130173 of Denosumab in Children and Young Adults With Osteogenesis ImperfectaTERMINATEDPHASE32018-07-262022-03-282022-03-28
NCT03512353A Study of Carfilzomib Plus Dexamethasone in Adults With Relapsed or Refractory Multiple Myeloma at US Community Oncology CentersTERMINATEDPHASE22018-07-052020-01-162020-01-16
NCT03298412Effect of Blinatumomab on Minimal Residual Disease (MRD) in Diffuse Large B-Cell Lymphoma (DLBCL) Subjects Post Autologous Hematopoietic Stem Cell Transplantation (aHSCT)TERMINATEDPHASE22018-05-232019-09-302019-09-30
NCT03410056Safety and Efficacy of Efavaleukin Alfa in Subjects With Active Rheumatoid ArthritisTERMINATEDPHASE1, PHASE22018-05-222020-05-132019-12-10
NCT03536754A Study of CCX140-B in Subjects With FSGSCOMPLETEDPHASE22018-05-172020-02-192020-02-19
NCT03299244Head-to-Head Study of Etelcalcetide and Cinacalcet in Asian Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT)COMPLETEDPHASE32018-05-152020-04-082020-04-08
NCT03164928Safety and Efficiency of Denosumab in Pediatric Subjects With Glucocorticoid-induced OsteoporosisCOMPLETEDPHASE32018-05-072023-12-202021-12-13
NCT03499119AMG 334 20160172 Pediatric Migraine PK Study.COMPLETEDPHASE12018-05-042021-11-232021-11-23
NCT03422627Safety and Efficacy of Efavaleukin Alfa in Subjects With Steroid Refractory Chronic Graft Versus Host DiseaseTERMINATEDPHASE1, PHASE22018-04-272022-10-132022-10-13
NCT03296696Study of AMG 596 in Patients With EGFRvIII Positive GlioblastomaTERMINATEDPHASE12018-04-182021-08-282021-07-01
NCT06004934A Study to Evaluate the Pharmacokinetics of Avacopan (CCX168) in Participants With Mild or Moderate Hepatic ImpairmentCOMPLETEDPHASE12018-04-172018-09-182018-09-18
NCT03461211Treatment of Graves' Orbitopathy to Reduce Proptosis With Teprotumumab Infusions in an Open-Label Clinical Extension StudyCOMPLETEDPHASE32018-04-162021-02-172020-06-08
NCT03451422Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Efavaleukin Alfa in Participants With Systemic Lupus ErythematosusCOMPLETEDPHASE12018-04-102021-10-122021-10-12
NCT03256344Study of Talimogene Laherparepvec With Atezolizumab for Triple Negative Breast Cancer and Colorectal Cancer With Liver MetastasesCOMPLETEDPHASE12018-03-192021-12-032020-05-26
NCT03340766Study Investigating the Safety and Efficacy of Blinatumomab in Combination With Pembrolizumab in Adults With Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)COMPLETEDPHASE12018-03-162023-08-142020-11-06
NCT03283098A Phase 1 Study to Evaluate PK, Safety and Tolerability of AMG 416COMPLETEDPHASE12018-03-012019-02-042019-02-04
NCT03335488Study of Glycerol Phenylbutyrate & Sodium Phenylbutyrate in Phenylbutyrate Naïve Patients With Urea Cycle Disorders (UCDs)COMPLETEDPHASE42018-02-202022-12-202022-07-05
NCT03432533A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for OsteoporosisCOMPLETEDPHASE32018-02-062020-01-082019-04-11
NCT03343847Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Lymphoma.WITHDRAWNPHASE32018-01-272021-07-172021-07-17
NCT03319940Study Evaluating Safety, Tolerability and Pharmacokinetics (PK) of Tarlatamab in Adults With Small Cell Lung Cancer (SCLC)ACTIVE_NOT_RECRUITINGPHASE12017-12-262026-10-182025-10-18
NCT03318809Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 986 Administered Orally to Healthy Volunteers and Participants With Severely Impaired Renal FunctionCOMPLETEDPHASE12017-12-122018-04-052018-03-12
NCT03287908A Study to Assess AMG 701 Montherapy, or in Combination With Pomalidomide, With or Without, Dexamethasone in Subjects With Relapsed or Refractory Multiple MyelomaTERMINATEDPHASE12017-11-132023-06-302023-06-30
NCT03301857Long-term Safety Follow-up of Subjects With Giant Cell Tumor of Bone Treated With Denosumab in Study 20062004COMPLETEDPHASE42017-11-132023-07-272023-07-27
NCT05988008A Study of CCX168 in Japanese and Caucasian Healthy Adult MalesCOMPLETEDPHASE12017-10-232018-09-202018-01-26
NCT03476239Efficacy and Safety of the BiTE Antibody Blinatumomab in Chinese Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)COMPLETEDPHASE32017-10-182021-04-082019-08-21
NCT03298867Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical StudyCOMPLETEDPHASE32017-10-042020-11-302019-02-13
NCT03301467Controlled Trial Evaluating Avacopan in C3 GlomerulopathyCOMPLETEDPHASE22017-09-292021-10-272021-03-03
NCT03456856A Study of Ivabradine in African-American/ Black Subjects With Heart Failure and Left Ventricular Systolic Dysfunction.COMPLETEDPHASE42017-09-282019-05-202019-04-19
NCT02961881A Phase 1b Open-Label Study Investigating the Safety and Pharmacokinetics of Administration of Subcutaneous Blinatumomab for the Treatment of Relapsed/Refractory Indolent Non-Hodgkin's LymphomaCOMPLETEDPHASE12017-09-182021-09-022021-09-02
NCT03224819Study of Emerfetamab (AMG 673) in Adults With Relapsed/Refractory Acute Myeloid Leukemia (AML)TERMINATEDEARLY_PHASE12017-09-072020-12-282020-12-28
NCT03238781Study to Evaluate the Efficacy and Safety of AMG 301 in Migraine PreventionCOMPLETEDPHASE22017-09-062019-02-042018-10-16
NCT02756845Study of Talimogene Laherparepvec In Children With Advanced Non CNS TumorsCOMPLETEDPHASE12017-08-162022-11-292022-01-17
NCT03156023Multiple Ascending Doses of Rozibafusp Alfa (AMG 570) in Adults With Rheumatoid ArthritisCOMPLETEDPHASE12017-08-142020-06-122019-10-17
NCT03158688Study of Carfilzomib, Daratumumab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma.COMPLETEDPHASE32017-06-132022-04-152019-07-14
NCT05913115A Study Evaluating Safety and Pharmacokinetics of FPA144 in Japanese Patients With Advanced Gastric or Gastroesophageal CancerCOMPLETEDPHASE12017-06-122018-06-192018-06-19
NCT02833844Safety, Tolerability and Efficacy on Low Density Lipoprotein Cholesterol (LDL-C) of Evolocumab in Participants With Human Immunodeficiency Virus (HIV) and Hyperlipidemia/Mixed DyslipidemiaCOMPLETEDPHASE32017-05-222020-01-272019-07-09
NCT03123471A Study of the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Moderate to Severe Plaque Psoriasis of the ScalpCOMPLETEDPHASE32017-05-162019-01-092018-08-13
NCT03170193AMG 529 First in Human StudyCOMPLETEDPHASE12017-05-152017-11-172017-11-17
NCT03029234Carfilzomib in Combination With Dexamethasone (Kd) in Chinese Patients With Relapsed & Refractory Multiple MyelomaCOMPLETEDPHASE32017-03-312021-06-042018-11-05
NCT02994927A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated VasculitisCOMPLETEDPHASE32017-03-152019-11-012019-09-07
NCT02833857A Single-dose Study in Paediatric Patients Aged 2 to Less Than 18 Years With Secondary Hyperparathyroidism (sHPT) Receiving HaemodialysisCOMPLETEDPHASE12017-03-142018-10-312018-10-31
NCT03080935Fourier Open-label Extension Study in Subjects With Clinically Evident Cardiovascular Disease in Selected European CountriesTERMINATEDPHASE32017-03-132022-03-042022-03-04
NCT03023878Safety and Efficacy of Blinatumomab in Adults With Newly Diagnosed High-risk Diffuse Large B-Cell LymphomaCOMPLETEDPHASE22017-03-132019-10-282019-04-04
NCT03064763Study to Evaluate the Safety/ Efficacy of T-VEC in Japanese Subjects With Unresectable Stage IIIB-IV Malignant MelanomaCOMPLETEDPHASE12017-03-072023-01-122020-08-03
NCT02910063Study to Evaluate Safety and Efficacy of Blinatumomab in Subjects With Relapsed/Refractory (R/R) Aggressive B-Cell NHLCOMPLETEDPHASE2, PHASE32017-01-232020-03-122020-03-12
NCT02939183Phase 1b Study Evaluating OPomD in Relapsed or Refractory Multiple MyelomaCOMPLETEDPHASE12017-01-172022-10-062022-10-06
NCT02791516A Safety and Efficacy Study to Evaluate Romosozumab (AMG 785) in South Korean Women With OsteoporosisCOMPLETEDPHASE32017-01-162018-12-212018-02-12
NCT02986139Study to Assess the Injection Site Pain Associated With a New Etanercept Formulation in Adults With Rheumatoid Arthritis or Psoriatic ArthritisCOMPLETEDPHASE32016-11-292017-10-092017-09-08
NCT02937701Study to Assess if ABP710 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis Compared to InfliximabCOMPLETEDPHASE32016-10-102018-08-132018-04-16
NCT02624869Safety, Tolerability and Efficacy of Evolocumab (AMG 145) in Children With Inherited Elevated Low-density Lipoprotein Cholesterol (Familial Hypercholesterolemia)COMPLETEDPHASE32016-09-102021-06-012021-06-01
NCT02867813Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk Open-label ExtensionCOMPLETEDPHASE32016-09-022022-03-212022-03-21
NCT02780674A Phase 1 Study of MEDI7734 in Type I Interferon-Mediated Autoimmune DiseasesCOMPLETEDPHASE12016-08-262017-11-272017-10-23
NCT02777554A Study to Evaluate the Pharmacokinetic Exposure of 2 Formulations of Apremilast in Healthy AdultsCOMPLETEDPHASE12016-08-172016-11-222016-11-22
NCT03276728Study to Evaluate the Safety and Tolerability of AMG 986 in Healthy Volunteers and Heart Failure PatientsTERMINATEDPHASE12016-08-122019-04-182019-04-18
NCT02797080Long-Term Safety Extension Study of ACTIMMUNE® (Interferon γ-1b) in Children and Young Adults With Friedreich's AtaxiaCOMPLETEDPHASE32016-06-282017-03-312017-03-31
NCT02802735Study to Evaluate the Pharmacokinetics of Single and Multiple Doses of Apremilast in Healthy Adult Male Korean SubjectsCOMPLETEDPHASE12016-06-222016-08-052016-08-05
NCT02675452AMG 176 First in Human Trial in Participants With Relapsed or Refractory Multiple Myeloma and Participants With Relapsed or Refractory Acute Myeloid LeukemiaTERMINATEDPHASE12016-06-132024-05-272024-05-27
NCT02747043Study to Assess if ABP798 is Safe & Effective in Treating Non Hodgkin Lymphoma Compared to RituximabCOMPLETEDPHASE32016-05-252019-06-282019-06-28
NCT02749370Study to Evaluate the Efficacy of Etanercept Treatment in Adults Who Failed Therapy With ApremilastCOMPLETEDPHASE42016-05-182017-12-062017-08-14
NCT02792699Study to Assess if ABP 798 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis (RA) Compared to RituximabCOMPLETEDPHASE32016-05-172018-10-082018-10-08
NCT02739984Evaluation of Evolocumab (AMG 145) Efficacy in Diabetic Adults With Hypercholesterolemia/Mixed DyslipidemiaCOMPLETEDPHASE32016-05-172017-08-032017-08-03
NCT02780388A Phase 1b Study of MEDI4920 in Participants With Adult-onset Rheumatoid ArthritisCOMPLETEDPHASE12016-05-122018-08-092018-05-21
NCT02729025Effects of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition on Arterial Wall Inflammation in Patients With Elevated Lipoprotein(a) (Lp(a))COMPLETEDPHASE32016-04-142018-04-052018-04-05
NCT02662569Safety and Efficacy of Evolocumab in Combination With Statin Therapy in Adults With Diabetes and Hyperlipidemia or Mixed DyslipidemiaCOMPLETEDPHASE32016-04-142017-12-062017-12-06
NCT02633020Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Type II Refractory Celiac DiseaseCOMPLETEDPHASE22016-04-132017-05-022017-04-11
NCT02637141A Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Celiac DiseaseCOMPLETEDPHASE22016-04-132017-03-142017-02-15
NCT02626000Talimogene Laherparepvec With Pembrolizumab for Recurrent Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY232 / KEYNOTE-137)COMPLETEDPHASE12016-04-062020-08-282017-11-02
NCT01428154Study to Evaluate Darbepoetin Alfa in Pediatric Subjects With Anemia Due to Chronic Kidney DiseaseWITHDRAWNPHASE12016-042016-112016-11
NCT02618967Single Ascending Dose Study of AMG 570 in Healthy SubjectsCOMPLETEDPHASE12016-03-282018-12-032018-09-06
NCT02392559Trial Assessing Efficacy, Safety and Tolerability of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition in Paediatric Subjects With Genetic Low-Density Lipoprotein (LDL) DisordersCOMPLETEDPHASE32016-03-242019-11-252019-11-25
NCT02634580Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-4COMPLETEDPHASE32016-02-272018-05-262017-08-10
NCT02741310Study to Evaluate the Effect of Erenumab on Blood Pressure When Given Concomitantly With Subcutaneous SumatriptanCOMPLETEDPHASE12016-02-222016-08-112016-08-11
NCT02792517Erenumab (AMG 334) Plus Combined Oral Contraceptive Drug Interaction Study in Healthy FemalesCOMPLETEDPHASE12016-02-122016-09-092016-09-09
NCT02509507Trial to Evaluate the Safety of Talimogene Laherparepvec Injected Into Tumors Alone and in Combination With Systemic Pembrolizumab MK-3475-611/Keynote-611COMPLETEDPHASE1, PHASE22016-02-052023-07-112022-02-14
NCT06004947A Study in Healthy Volunteers to Evaluate the Drug-Drug Interaction Potential of CCX168 With Concomitant MedicationsCOMPLETEDPHASE12016-01-142016-06-102016-03-15
NCT02630459A Safety and Efficacy Study to Evaluate AMG 334 in Migraine PreventionCOMPLETEDPHASE22016-01-062019-06-052017-09-25
NCT02641353Study to Evaluate Bioavailability of Apremilast Oral Suspension Relative to Tablet and to Assess Effect of Food on the Pharmacokinetics (PK) of the Oral SuspensionCOMPLETEDPHASE12016-01-052016-02-272016-02-27
NCT02593773Safety, Tolerability and Efficacy of ACTIMMUNE® Dose Escalation in Friedreich's Ataxia StudyCOMPLETEDPHASE32015-12-252017-03-212017-03-21
NCT02576652Bone Histomorphometry in Postmenopausal Men and Women With Osteoarthritis Undergoing Total Hip ReplacementCOMPLETEDPHASE42015-12-222017-12-182017-12-18
NCT02585895Evolocumab Compared to LDL-C Apheresis in Patients Receiving LDL-C Apheresis Prior to Study EnrollmentCOMPLETEDPHASE32015-12-212017-01-202016-09-01
NCT05988021A Study in Healthy Volunteers to Evaluate the Pharmacokinetic Food Effect and Cardiac Safety of CCX168COMPLETEDPHASE12015-12-032016-05-252016-02-09
NCT02575833Treadmill Cardiovascular Safety Study of Erenumab (AMG 334)COMPLETEDPHASE22015-11-232017-04-132017-01-23
NCT02561962A Phase 1 Study in Subjects With Relapsed or Refractory Multiple MyelomaCOMPLETEDPHASE12015-11-202022-04-212018-11-30
NCT02542605To Evaluate the Blockade of CGRP in Preventing PACAP-38 Induced Migraine-like Attacks With AMG 334 in Migraine PatientsCOMPLETEDPHASE12015-11-112017-11-082017-09-28
NCT02393859Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HIgh-Risk (HR) First Relapse B-precursor Acute Lymphoblastic Leukemia (ALL)COMPLETEDPHASE32015-11-102022-11-212019-07-17
NCT05873907A Study to Evaluate the Safety, Tolerability, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AMG 592 in Healthy ParticipantsCOMPLETEDPHASE12015-10-192017-07-282017-06-16
NCT02576678A Study of Safety, Tolerability and Pharmacokinetics of Apremilast (CC-10004) in Pediatric Subjects With Moderate to Severe Plaque PsoriasisCOMPLETEDPHASE22015-10-132019-07-292017-09-04
NCT02412878Once-weekly Versus Twice-weekly Carfilzomib in Combination With Dexamethasone in Adults With Relapsed and Refractory Multiple MyelomaCOMPLETEDPHASE32015-09-092019-01-072017-06-15
NCT02520427A Phase 1 Study of AMG 330 in Subjects With Myeloid MalignanciesTERMINATEDPHASE12015-08-312022-01-092022-01-09
NCT02504476Multiple Ascending Dose Study on Safety, Tolerability, and Pharmacokinetics of AMG 581 in Healthy Subjects or Subjects With Schizophrenia or SchizoaffectiveCOMPLETEDPHASE12015-082016-022016-02
NCT02567370Single-ascending Dose Study With a Food-Effect Cohort to Evaluate AMG 581COMPLETEDPHASE12015-082015-102015-10
NCT02483585Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) Compared to Placebo in Migraine PreventionCOMPLETEDPHASE32015-07-202017-03-202016-07-11
NCT02456740Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine PreventionCOMPLETEDPHASE32015-07-172017-06-192016-09-05
NCT02352753Multicenter,Single-arm Study to Evaluate Efficacy, Safety, & Pharmacokinetics of Denosumab in Children w/ OITERMINATEDPHASE32015-06-242022-03-262022-03-26
NCT02341417Extension Study of Cinacalcet for Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Patients With Chronic Kidney Disease on DialysisCOMPLETEDPHASE32015-06-102017-03-152017-03-15
NCT02412306Study of Blinatumomab in Japanese Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic LeukemiaCOMPLETEDPHASE1, PHASE22015-06-042019-07-042019-02-06
NCT02415127Safety, Tolerability and Efficacy of ACTIMMUNE® Dose Escalation in Friedreich's AtaxiaCOMPLETEDPHASE32015-062016-112016-11
NCT02473445A Long-term Extension of Study RP103-MITO-001 (NCT02023866) to Assess Cysteamine Bitartrate Delayed-release Capsules (RP103) in Children With Inherited Mitochondrial DiseaseTERMINATEDPHASE22015-05-192017-03-062017-03-06
NCT02429882Study of Efficacy and Safety of Brodalumab Compared With Placebo in Subjects With Axial SpondyloarthritisWITHDRAWNPHASE22015-052015-052015-05
NCT02335983Phase 1b Study of Weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple MyelomaCOMPLETEDPHASE12015-04-302019-10-282019-10-28
NCT02437916Safety Study of AMG 228 to Treat Solid TumorsTERMINATEDPHASE12015-04-212016-12-122016-12-12
NCT02425826A Phase 4 Study of Efficacy and Safety of Apremilast in Subjects With Moderate Plaque Psoriasis.COMPLETEDPHASE42015-04-202016-11-222016-02-12
NCT02366195Single-arm Trial to Evaluate the Role of the Immune Response to Talimogene Laherparepvec in Unresected MelanomaCOMPLETEDPHASE22015-04-072020-12-252017-06-26
NCT02253654Evaluation of Two Epoetin Alfa Dosing Strategies in Subjects With Chronic Kidney Disease Receiving HemodialysisCOMPLETEDPHASE42015-04-012016-05-252016-04-27
NCT02346877Evaluate Effects of Personalized Patient Counselling for Enbrel® Therapy in Adults With Rheumatoid ArthritisTERMINATEDPHASE42015-042015-102015-10
NCT02499315Study to Evaluate the Safety, Tolerability, and Action of AMG 357 in Females With Rheumatoid ArthritisTERMINATEDPHASE12015-042016-022016-02
NCT02384317Open-Label Study to Evaluate Safety and Efficacy of CCX168 in Subjects With IGA Nephropathy on Stable RAAS BlockadeCOMPLETEDPHASE22015-03-272018-06-012015-09-13
NCT02376790Etanercept and Methotrexate in Combination or as Monotherapy in Psoriatic ArthritisCOMPLETEDPHASE32015-03-032018-07-062018-01-09
NCT02373813Study of Etanercept Monotherapy vs Methotrexate Monotherapy for Maintenance of Rheumatoid Arthritis RemissionCOMPLETEDPHASE32015-02-202019-12-062019-12-06
NCT02303821Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic LeukemiaCOMPLETEDPHASE12015-02-162024-06-282024-06-28
NCT02222155Clinical Trial to Evaluate Safety and Efficacy of CCX168 in ANCA-Associated VasculitisCOMPLETEDPHASE22015-02-042016-07-192016-04-24
NCT02211131Efficacy and Safety of Talimogene Laherparepvec Neoadjuvant Treatment Plus Surgery Versus Surgery Alone for MelanomaCOMPLETEDPHASE22015-02-032022-04-282019-04-30
NCT02345408Phase 1b Study of CCX872-B in Patients With Pancreatic AdenocarcinomaCOMPLETEDPHASE12015-022020-05-062020-05-06
NCT02289417Efficacy and Safety Study of Apremilast to Treat Active Ulcerative ColitisCOMPLETEDPHASE22015-01-082019-06-032017-09-25
NCT02274792Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Patients With Plaque PsoriasisCOMPLETEDPHASE42015-012015-112015-11
NCT02246218A Study of the Safety, Efficacy and Pharmacokinetics of Glycerol Phenylbutyrate in Pediatric Subjects Under 2 Years of Age With Urea Cycle DisordersCOMPLETEDPHASE42014-12-312017-07-172016-10-17
NCT02307513A Phase 3 Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Active Behçet's DiseaseCOMPLETEDPHASE32014-12-302020-07-172017-09-25
NCT02279173Long-term Study of Romiplostim in Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP)COMPLETEDPHASE32014-12-102019-08-082018-08-30
NCT02263508Pembrolizumab With Talimogene Laherparepvec or Placebo in Unresected MelanomaTERMINATEDPHASE32014-12-082021-03-112021-03-11
NCT02227914Phase 1b/2 Study of Oprozomib in Combination With Sorafenib in Subjects With Advanced Hepatocellular CarcinomaWITHDRAWNPHASE1, PHASE22014-122015-032015-03
NCT02291614A Phase 1 Study of AMG 211 in Participants With Advanced Gastrointestinal CancerTERMINATEDPHASE12014-11-272018-01-092017-11-06
NCT05995691Study to Determine the Pharmacokinetic (PK) Bioequivalence of ABP 501 and Adalimumab (Humira®) in Healthy Adult Japanese ParticipantsCOMPLETEDPHASE12014-11-242015-12-042015-12-04
NCT02304484Open-label Extension (OLE) Study to Assess Safety and Efficacy of EvolocumabCOMPLETEDPHASE32014-11-242018-03-092018-03-09
NCT02138838Efficacy and Safety of Cinacalcet in Pediatric Patients With Secondary Hyperparathyroidism (SHPT) and Chronic Kidney Disease (CKD) on DialysisTERMINATEDPHASE32014-11-072016-06-232016-06-23
NCT02101164Evaluate Time Associated With the Preparation & Administration of Denosumab/Pamidronate in Patients With Solid Tumors and Metastatic Bone DiseaseWITHDRAWNPHASE42014-112014-112014-11
NCT06004960A Study to Assess the Mass Balance Recovery (Absorption, Distribution, Metabolism and Excretion) of [14C]CCX168 in Healthy ParticipantsCOMPLETEDPHASE12014-10-202014-12-052014-12-05
NCT02103283A Phase 1, Open-Label Study of Teprotumumab in Patients With Diabetic Macular Edema (DME)COMPLETEDPHASE12014-102016-082016-08
NCT02207634Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk SubjectsCOMPLETEDPHASE32014-09-102016-11-112016-11-11
NCT02275156Estimation Study to Assess the Effect of Severe Renal Impairment and End-stage Renal Disease Hemodialysis on the Pharmacokinetics of EvolocumabCOMPLETEDPHASE12014-08-192014-12-192014-12-19
NCT02244112A Phase 1 Study of Oprozomib to Assess Food Effect, Drug-Drug Interaction With Midazolam, and Safety and Tolerability in Patients With Advanced MalignanciesTERMINATEDPHASE12014-082019-07-102015-05-15
NCT01999335A Study of Oprozomib, Pomalidomide, and Dexamethasone in Adults With Primary Refractory or Relapsed and Refractory Multiple MyelomaTERMINATEDPHASE12014-07-302019-04-252019-04-25
NCT02189837Effects on Lipoprotein Metabolism From PCSK9 Inhibition Utilizing a Monoclonal AntibodyCOMPLETEDPHASE32014-07-082015-03-052015-02-13
NCT02170337A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 282 in Healthy Subjects and Subjects With Chronic Rhinosinusitis With Nasal PolypsCOMPLETEDPHASE12014-072016-052016-05
NCT02137343A Phase 3 Study of Rilotumumab (AMG 102) With Cisplatin and Capecitabine (CX) as First-line Therapy in Gastric CancerTERMINATEDPHASE32014-072015-062015-06
NCT02174861A Study to Assess the Long-term Safety and Efficacy of Erenumab (AMG 334) in Chronic Migraine Prevention.COMPLETEDPHASE22014-06-302017-05-262017-05-26
NCT02186171A Study to Compare the Safety and Efficacy of Romosozumab (AMG 785) Versus Placebo in Men With OsteoporosisCOMPLETEDPHASE32014-06-162016-04-202016-02-15
NCT02175277Darbepoetin Alfa MDS Companion ProtocolCOMPLETEDPHASE32014-06-122017-03-202017-03-20
NCT02087943Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic DermatitisCOMPLETEDPHASE22014-062016-022015-10
NCT02023866Open-Label, Dose-Escalating Study Assessing Safety, Tolerability, Efficacy, of RP103 in Mitochondrial DiseaseCOMPLETEDPHASE22014-052016-102016-10
NCT02157948A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With OsteoporosisCOMPLETEDPHASE32014-052015-072015-07
NCT02132429Phase I, Double-Blind,Placebo, MAD Study to Evaluate the Safety, Tolerability, PK, and PD of AMG 333 in Healthy Subjects and Migraine SubjectsTERMINATEDPHASE12014-052014-122014-10
NCT02096666A Phase 1/2 Study Evaluating AMG 337 in Asian SubjectsCOMPLETEDPHASE1, PHASE22014-04-152018-12-072015-11-05
NCT02014441Single-arm Trial to Evaluate the Biodistribution and Shedding of Talimogene LaherparepvecCOMPLETEDPHASE22014-04-072018-04-192016-01-25
NCT02114931Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid ArthritisCOMPLETEDPHASE32014-042016-042016-04
NCT02099461Effect of Denosumab on Cellular Biomarkers in the Human BreastCOMPLETEDPHASE12014-042014-072014-07
NCT02102204Extension Study of Etelcalcetide for Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease on HemodialysisCOMPLETEDPHASE32014-03-252017-06-262016-11-04
NCT02066415A Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Chronic Migraine PreventionCOMPLETEDPHASE22014-03-052016-04-282016-02-24
NCT02054572Pharmacokinetics and Excretion of [¹⁴C]Etelcalcetide (AMG 416) in Patients With End Stage Renal Disease (ESRD) Receiving DialysisCOMPLETEDPHASE12014-02-072014-08-152014-04-15
NCT02053753Bioequivalence Study of Denosumab CP4 Drug Product and Commercially Available Denosumab CP2 Drug ProductCOMPLETEDPHASE12014-022014-082014-08
NCT02016534Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid TumorsTERMINATEDPHASE22014-022016-102016-10
NCT02236988Study to Evaluate Pharmacokinetics of Prototype Modified-Release Formulations Of Apremilast in Healthy MenCOMPLETEDPHASE12014-01-072014-09-112014-09-11
NCT02000427Blinatumomab in Adults With Relapsed/Refractory Philadelphia Positive B-precursor Acute Lymphoblastic LeukemiaCOMPLETEDPHASE22014-01-032017-01-062015-05-20
NCT02013167Blinatumomab Versus Standard of Care Chemotherapy in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)TERMINATEDPHASE32014-01-032017-03-142015-12-29
NCT02072863A Study of Oprozomib, Melphalan, and Prednisone in Transplant Ineligible Patients With Newly Diagnosed Multiple MyelomaCOMPLETEDPHASE1, PHASE22014-012015-092015-01
NCT01949532Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Multiple Myeloma and Renal DiseaseCOMPLETEDPHASE12014-012017-012015-04
NCT01951586Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung CancerCOMPLETEDPHASE22013-12-312017-11-282016-07-29
NCT01984424Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects-3COMPLETEDPHASE32013-12-102017-11-212015-11-10
NCT02016716A Randomized Phase 3 Study to Evaluate Two Formulations of Romosozumab in Postmenopausal Women With OsteoporosisCOMPLETEDPHASE32013-12-032014-12-082014-09-08
NCT01966003Efficacy and Safety Study of ABP 215 Compared With Bevacizumab in Patients With Advanced Non-Small Cell Lung CancerCOMPLETEDPHASE32013-11-112015-07-232015-07-23
NCT01987232Phase 1b/2 Study of Carfilzomib, Carboplatin, and Etoposide in Patients With Previously Untreated Extensive Stage Small-cell Lung CancerCOMPLETEDPHASE1, PHASE22013-11-052017-05-042016-08
NCT01881789Oprozomib and Dexamethasone,in Combination With Lenalidomide or Oral Cyclophosphamide to Treat Newly Diagnosed Multiple MyelomaTERMINATEDPHASE1, PHASE22013-10-282019-09-232019-09-23
NCT01970488Study to Compare Efficacy and Safety of ABP 501 and Adalimumab (HUMIRA®) in Adults With Moderate to Severe Plaque PsoriasisCOMPLETEDPHASE32013-10-182015-03-182014-08-14
NCT01949545Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Advanced Malignancies and Hepatic ImpairmentCOMPLETEDPHASE12013-102015-092015-08
NCT01970475Efficacy and Safety Study of ABP 501 Compared to Adalimumab in Subjects With Moderate to Severe Rheumatoid ArthritisCOMPLETEDPHASE32013-102014-112014-11
NCT01953328Study of Low-Density Lipoprotein Cholesterol (LDL-C) Reduction Using Evolocumab (AMG 145) in Japanese Patients With Advanced Cardiovascular RiskCOMPLETEDPHASE32013-102014-062014-06
NCT01953341Single-Ascending Dose Study of AMG 333 in Healthy Subjects and Subjects With MigrainesCOMPLETEDPHASE12013-102014-112014-09
NCT01925768Safety and Efficacy Study of Apremilast to Treat Psoriatic ArthritisCOMPLETEDPHASE32013-09-042016-11-172015-02-25
NCT01896232Head-to-Head Study of Etelcalcetide (AMG 416) and CinacalcetCOMPLETEDPHASE32013-08-132015-01-082014-11-12
NCT01932970Study to Assess the Impact on Calcium Levels When Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT) Switch From Cinacalcet to EtelcalcetideCOMPLETEDPHASE32013-08-122017-02-142014-01-14
NCT01952574Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine PreventionCOMPLETEDPHASE22013-08-062019-11-122014-09-25
NCT01980589A Multicenter, Open-label, Phase 1b Study of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma SubjectsCOMPLETEDPHASE12013-082016-032016-03
NCT01928368A First-in-Human, Double Blind, Single Dose Study in Healthy Subjects and Subjects With Mild Atopic Asthma.COMPLETEDPHASE12013-082016-032016-03
NCT01785875Extension Study of Etelcalcetide in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on HemodialysisCOMPLETEDPHASE32013-07-312015-07-012015-07-01
NCT01879319Study to Assess in Home Use of Evolocumab (AMG 145) Administration Using Either an Automated Mini-doser or a Prefilled Autoinjector/PenCOMPLETEDPHASE32013-07-112013-11-15
NCT01988103Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Patients With Moderate-To-Severe Plaque-Type PsoriasisCOMPLETEDPHASE22013-07-092015-12-152014-11-20
NCT01818752Phase 3 Study of Carfilzomib, Melphalan, Prednisone vs Bortezomib, Melphalan, Prednisone in Newly Diagnosed Multiple MyelomaCOMPLETEDPHASE32013-07-082016-11-042016-07-15
NCT01832727Phase 1b/2, Multicenter, Open-label Study of Oprozomib and Dexamethasone in Patients With Relapsed and/or Refractory Multiple MyelomaTERMINATEDPHASE1, PHASE22013-07-022019-06-252019-06-25
NCT01868997Teprotumumab (RV 001) Treatment in Patients With Active Thyroid Eye DiseaseCOMPLETEDPHASE22013-072017-02-222016-03
NCT01901185Study to Evaluate the Ability of Subjects With Rheumatoid Arthritis or Psoriatic Arthritis to Effectively Use a Reusable Autoinjector to Self-inject EtanerceptCOMPLETEDPHASE32013-06-112013-12-302013-12-18
NCT01875991Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With EtanerceptCOMPLETEDPHASE42013-06-052014-03-042014-03-04
NCT01869686Study to Evaluate the Concentration of Denosumab in Seminal Fluid in Healthy Men After a Single Subcutaneous DoseCOMPLETEDPHASE12013-062013-092013-09
NCT01902290Study of Efficacy and Safety of Brodalumab Compared With Placebo in Adults With Inadequately Controlled Asthma With High Bronchodilator ReversibilityTERMINATEDPHASE22013-05-222015-05-152015-05-15
NCT01890109Study of Erenumab (AMG 334) in Women With Hot FlashesCOMPLETEDPHASE12013-05-132014-03-112014-03-11
NCT01927757Evaluating Etanercept Use in Patients With Moderate to Severe Rheumatoid Arthritis Who Have Lost Response to AdalimumabTERMINATEDPHASE42013-05-062015-06-112015-06-11
NCT01901146Efficacy and Safety Study of ABP 980 Compared With Trastuzumab in Women With HER2-positive Early Breast CancerCOMPLETEDPHASE32013-04-292017-01-272016-05-05
NCT01854918Open-label Extension Study of Evolocumab (AMG 145) in Adults With Hyperlipidemia and Mixed DyslipidemiaCOMPLETEDPHASE32013-04-232018-05-312018-05-31
NCT01833754Study of Romosozumab (AMG 785) Administered to Healthy Participants and Patients With Stage 4 Renal Impairment or Stage 5 Renal Impairment Requiring HemodialysisCOMPLETEDPHASE12013-04-222014-02-192014-02-19
NCT01813422GLobal Assessment of Plaque reGression With a PCSK9 antibOdy as Measured by intraVascular UltrasoundCOMPLETEDPHASE32013-04-182016-07-292016-07-12
NCT01849497Study to Assess In-home Use of Evolocumab (AMG 145) Using a Prefilled Syringe or a Prefilled Autoinjector/PenCOMPLETEDPHASE32013-04-182013-09-02
NCT01788046Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on HemodialysisCOMPLETEDPHASE32013-03-122014-05-092014-04-14
NCT01785849Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease on HemodialysisCOMPLETEDPHASE32013-03-122014-06-122014-05-22
NCT01856881Multiple Ascending Dose Study in Subjects With Type 2 DiabetesTERMINATEDPHASE12013-032015-032014-11
NCT01764633Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated RiskCOMPLETEDPHASE32013-02-082016-11-112016-11-11
NCT01740297Ipilimumab With or Without Talimogene Laherparepvec in Unresected MelanomaCOMPLETEDPHASE1, PHASE22013-02-072021-03-092016-08-23
NCT01763918Reduction of LDL-C With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study-2COMPLETEDPHASE32013-02-072013-12-192013-11-27
NCT01733316Open-Label, Safety and Superior Effectiveness Study of Cysteamine Bitartrate Delayed-Release Capsules (RP103) in CystinosisCOMPLETEDPHASE32013-01-312017-07-102015-02
NCT01796301An Open-label Study to Evaluate the Effect of Treatment With Romosozumab or Teriparatide in Postmenopausal WomenCOMPLETEDPHASE32013-01-312015-05-142015-05-14
NCT01763905Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects -2COMPLETEDPHASE32013-01-242013-11-192013-11-19
NCT01763827Monoclonal Antibody Against PCSK9 to Reduce Elevated LDL-C in Subjects Currently Not Receiving Drug Therapy for Easing Lipid Levels-2COMPLETEDPHASE32013-01-212013-10-292013-10-10
NCT01752907Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and PegfilgrastimCOMPLETEDPHASE22013-01-172014-12-152014-12-15
NCT01763866LDL-C Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2COMPLETEDPHASE32013-01-152013-12-042013-11-12
NCT01744782Safety/Effectiveness Study of Cysteamine Bitartrate Delayed-release Capsules (RP103) in Cysteamine Treatment Naive Patients With CystinosisCOMPLETEDPHASE32012-12-202016-12-132016-12-13
NCT01696396Abrilumab (AMG 181) in Adults With Moderate to Severe Crohn's DiseaseCOMPLETEDPHASE22012-12-042018-04-102014-12-26
NCT01694485Abrilumab (AMG 181) in Adults With Moderate to Severe Ulcerative ColitisCOMPLETEDPHASE22012-11-162018-04-102015-07-13
NCT01723514Ascending Multiple-Doses of Erenumab (AMG 334) in Healthy Adults and in Migraine PatientsCOMPLETEDPHASE12012-11-142014-07-102014-07-10
NCT01732770Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With OsteoporosisCOMPLETEDPHASE42012-11-072015-01-072015-01-07
NCT01712009NOLAN: Naproxen or Loratadine and NeulastaCOMPLETEDPHASE22012-11-012015-03-182015-03-18
NCT01791374Phase 1/1b Study of Rilotumumab in Japanese Subjects With Advanced Solid Tumors or Advanced or Metastatic Gastric or GEJCOMPLETEDPHASE12012-112015-032013-08
NCT01755442Investigate Effect of AMG 151 on 24-hour Ambulatory Blood Pressure & Glucose Levels in Type 2 Diabetes Mellitus SubjectsTERMINATEDPHASE12012-112013-012013-01
NCT01992159Efficacy, Safety and Tolerability of Romosozumab in the Treatment of Japanese Women With Postmenopausal OsteoporosisCOMPLETEDPHASE22012-10-122015-06-172014-10-09
NCT01690299Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque PsoriasisCOMPLETEDPHASE32012-10-012016-04-042014-07-03
NCT01697072First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) AdenocarcinomaTERMINATEDPHASE32012-102015-082014-11
NCT01695876A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), Food Effect of AMG 357 in Healthy SubjectsCOMPLETEDPHASE12012-102014-102014-09
NCT01737879Evaluation of the Conversion From Peginesatide to Epoetin Alfa in Patients Receiving HemodialysisTERMINATEDPHASE42012-102013-072013-03
NCT01666977Phase 1b/2 Trial of AMG386 With Pemetrexed and Carboplatin in Non-Small Cell Lung CancerCOMPLETEDPHASE1, PHASE22012-082015-112015-11
NCT01652872Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney DiseaseCOMPLETEDPHASE32012-07-302017-10-192017-10-19
NCT01652703A Study to Evaluate Tolerability and Efficacy of Evolocumab (AMG 145) in Japanese SubjectsCOMPLETEDPHASE22012-07-102013-05-14
NCT01677858A Study of Weekly Carfilzomib in Combination With Dexamethasone for Progressive Multiple MyelomaCOMPLETEDPHASE1, PHASE22012-07-042018-10-312016-07-22
NCT01741792Clinical Study With Blinatumomab in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)COMPLETEDPHASE22012-072015-092014-07
NCT01992341AMG 386 Drug-Drug Interaction Study With PaclitaxelCOMPLETEDPHASE12012-072014-092013-08
NCT01439867Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary HyperparathyroidismTERMINATEDPHASE22012-06-222016-06-032016-06-03
NCT01568866Phase 3 Study With Carfilzomib and Dexamethasone Versus Bortezomib and Dexamethasone for Relapsed Multiple Myeloma PatientsCOMPLETEDPHASE32012-06-202018-02-052014-11-10
NCT01624142Trial Assessing Long Term USe of PCSK9 Inhibition in Subjects With Genetic LDL DisordersCOMPLETEDPHASE2, PHASE32012-06-012018-05-112018-05-11
NCT01683695Safety Study of AMG 557 in Subjects With Lupus ArthritisCOMPLETEDPHASE12012-062016-032016-03
NCT01345019Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple MyelomaCOMPLETEDPHASE32012-05-172019-03-292016-07-19
NCT01631214Study to Determine the Efficacy and Safety of Romosozumab in the Treatment of Postmenopausal Women With OsteoporosisCOMPLETEDPHASE32012-05-042017-06-292017-02-27
NCT01583374Study of Apremilast to Treat Subjects With Active Ankylosing SpondylitisCOMPLETEDPHASE32012-05-022018-10-252014-02-24
NCT0156821620101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative SymptomsTERMINATEDPHASE22012-052013-062013-06
NCT0156822920110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms (Study 165)TERMINATEDPHASE22012-052013-082013-06
NCT01588496Trial Evaluating PCSK9 Antibody in Subjects With LDL Receptor AbnormalitiesCOMPLETEDPHASE2, PHASE32012-04-052014-01-312014-01-31
NCT01544114A Safety Study of VIMOVO in Adolescents With Juvenile Idiopathic Arthritis (JIA)COMPLETEDPHASE42012-042015-022015-02
NCT01563185Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic ArthritisCOMPLETEDPHASE42012-042015-032015-03
NCT01588509Transition From Alendronate to Romosozumab (AMG 785)COMPLETEDPHASE12012-03-302012-11-212012-11-21
NCT01575873Efficacy and Safety of Denosumab Compared With Risedronate in Individuals Taking GlucocorticoidsCOMPLETEDPHASE32012-03-282017-06-292016-06-21
NCT01575834Efficacy and Safety of Romosozumab Treatment in Postmenopausal Women With OsteoporosisCOMPLETEDPHASE32012-03-152016-12-282015-12-14
NCT01688739Ascending Single Doses of Erenumab (AMG 334) in Healthy Adults and Migraine PatientsCOMPLETEDPHASE12012-03-132013-03-272013-03-27
NCT01561963A Drug-Drug Interaction Study to Evaluate the Effect of Rifampin on the Pharmacokinetics of ApremilastCOMPLETEDPHASE12012-02-012012-04-012012-04-01
NCT01634178Effect of Food on the Pharmacokinetics of Apremilast (CC-10004) in Healthy AdultsCOMPLETEDPHASE12012-02-012012-03-012012-03-01
NCT01634191Effects of Age and Sex on the Pharmacokinetics of Apremilast in Healthy AdultsCOMPLETEDPHASE12012-02-012012-04-012012-03-01
NCT01543204Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to AdalimumabTERMINATEDPHASE42012-02-012015-05-292015-05-29
NCT01475006AMG 595 First-in-Human in Recurrent GliomasCOMPLETEDPHASE12012-022016-042016-04
NCT01516879Durable Effect of PCSK9 Antibody CompARed wiTh placEbo StudyCOMPLETEDPHASE32012-01-052013-10-142013-10-14
NCT01444417Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric PatientsCOMPLETEDPHASE32012-012015-022015-02
NCT01493505TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian CancerTERMINATEDPHASE32012-012016-122016-03
NCT01471782Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic LeukemiaCOMPLETEDPHASE1, PHASE22012-012016-052014-08
NCT01497821AMG 172 First in Human Study in Patients With Kidney CancerCOMPLETEDPHASE12012-012015-012014-11
NCT01362140Darbepoetin Alfa in Patients With Anemic Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)COMPLETEDPHASE32011-12-212017-09-142015-02-11
NCT01466179Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)COMPLETEDPHASE22011-122017-012013-10
NCT01514981AMG 761 in Adults With AsthmaTERMINATEDPHASE12011-122014-022014-01
NCT01419717Open-Label Access Protocol of Denosumab for Subjects With Advanced CancerCOMPLETEDPHASE32011-11-222018-08-102018-08-10
NCT01412957Comparison of Survival Benefit of Panitumumab With Supportive Care to Best Supportive Care Alone in Patients With Metastatic Colorectal CancerCOMPLETEDPHASE32011-112016-112014-06
NCT01464931Multiple Dose Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg in Adults With Severe Chronic Kidney Disease (CKD) and CKD on DialysisCOMPLETEDPHASE12011-112013-032013-01
NCT01493518Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of AMG 557 in Adults With PsoriasisTERMINATEDPHASE12011-112013-062013-05
NCT01492465Single Ascending Dose Trial in Patients With Type 2 DiabetesTERMINATEDPHASE12011-112012-102012-07
NCT01405963Double-blind, Multiple Dose Study of Tezepelumab (AMG 157) in Adults With Mild Atopic AsthmaCOMPLETEDPHASE12011-10-312013-04-052013-04-05
NCT01416428Open-label Study of the Safety and Activity of Oprozomib in Patients With Hematologic MalignanciesTERMINATEDPHASE1, PHASE22011-10-152019-08-122016-08-08
NCT01439880Open Label Study of Long Term Evaluation Against LDL-C TrialCOMPLETEDPHASE22011-10-072018-06-202018-06-20
NCT01380756Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Myeloid LeukemiaCOMPLETEDPHASE12011-10-042014-09-042014-09-04
NCT01447147A Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Diabetic NephropathyCOMPLETEDPHASE22011-102014-122014-08
NCT01389895Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus ErythematosusTERMINATEDPHASE12011-102013-032013-03
NCT01331941A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal FunctionCOMPLETEDPHASE12011-09-192013-02-26
NCT01363388A Study to Evaluate the Safety and Efficacy of CCX168 in Subjects With ANCA-Associated VasculitisCOMPLETEDPHASE22011-092016-012015-10
NCT01440257A Study to Evaluate the Effect of CCX140-B on Urinary Albumin Excretion in Subjects With Type 2 Diabetes and AlbuminuriaCOMPLETEDPHASE22011-092013-092013-02
NCT01464437AMG 151 Amgen Protocol Number 20100761COMPLETEDPHASE22011-092012-122012-10
NCT01568203First-in-Human Study to Evaluate AMG 579 in Healthy Subjects and Patients With Stable SchizophreniaTERMINATEDPHASE12011-092012-062012-06
NCT01375751Reduction of Low-Density Lipoprotein Cholesterol (LDL-C) With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder StudyCOMPLETEDPHASE22011-08-022012-05-162012-05-16
NCT01510951Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of AMG 811 in Subjects With PsoriasisCOMPLETEDPHASE12011-082012-102012-10
NCT01375764Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant SubjectsCOMPLETEDPHASE22011-07-282012-05-082012-05-08
NCT01375777Monoclonal Antibody Against PCSK9 to Reduce Elevated Low-density Lipoprotein Cholesterol (LDL-C) in Adults Currently Not Receiving Drug Therapy for Easing Lipid LevelsCOMPLETEDPHASE22011-07-062012-03-022012-03-02
NCT01347073Study of the Safety, Pharmacokinetics and Efficacy of HPN-100, in Pediatric Subjects With Urea Cycle Disorders (UCDs)COMPLETEDPHASE32011-072013-032013-02
NCT01380730LAPLACE-TIMI 57: Low-density Lipoprotein Cholesterol (LDL-C) Assessment With PCSK9 monoclonaL Antibody Inhibition Combined With Statin thErapyCOMPLETEDPHASE22011-07-012012-04-052012-04-05
NCT01277510Pediatric Chronic Kidney Disease Safety and EfficacyTERMINATEDPHASE32011-06-282014-04-30
NCT01395485Safety, Tolerability, and Pharmacokinetics of AMG 827 in Adolescents With AsthmaWITHDRAWNPHASE12011-062012-062012-06
NCT01281254AMG 386 (Trebananib) in Ovarian Cancer (TRINOVA-2)TERMINATEDPHASE32011-04-182017-04-192014-08-29
NCT01313221Efficacy and Safety of Etanercept 50 mg Once Weekly Plus As Needed Topical Agent in Moderate to Severe Plaque PsoriasisCOMPLETEDPHASE32011-042013-052012-12
NCT01300026AMG 319 Lymphoid Malignancy FIHCOMPLETEDPHASE12011-042016-122013-10
NCT01327612Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)COMPLETEDPHASE22011-03-032020-02-052020-02-05
NCT01294397Effects of Denosumab on the Pharmacokinetics of EtanerceptTERMINATEDPHASE12011-032016-012016-01
NCT01313208Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)COMPLETEDPHASE42011-032013-052013-02
NCT01199302Long-term Safety Study of Brodalumab in Adults With Crohn's DiseaseTERMINATEDPHASE22011-02-022011-10-182011-10-18
NCT01290042Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.COMPLETEDPHASE12011-022014-052014-04
NCT01290029Study to Evaluate Cinacalcet in Children With Chronic Kidney DiseaseCOMPLETEDPHASE12011-01-252015-09-232015-09-23
NCT01270347Trial of Aeroquin Versus Tobramycin Inhalation Solution (TIS) in Cystic Fibrosis (CF) PatientsCOMPLETEDPHASE32011-012013-062012-10
NCT01824342Denosumab for Prolonging Bone Metastasis-Free Survival in Men With Hormone-Refractory Prostate CancerCOMPLETEDPHASE32011-012014-022014-02
NCT01307423Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis (PsA)COMPLETEDPHASE32010-12-092017-08-162013-02-21
NCT01285310Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid ArthritisTERMINATEDPHASE22010-12-092012-09-102012-02-21
NCT01253707A Study of AMG 337 in Subjects With Advanced Solid TumorsCOMPLETEDPHASE12010-12-082016-12-132015-10-01
NCT01143038Interventional Study in Adults With Immune Thrombocytopenia Purpura (ITP) Receiving RomiplostimCOMPLETEDPHASE22010-11-302013-12-262013-09-20
NCT01232283Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis.COMPLETEDPHASE32010-11-222016-11-302012-03-15
NCT01150890Brodalumab (AMG 827) in Adults With Moderate to Severe Crohn's DiseaseTERMINATEDPHASE22010-11-092011-10-152011-10-15
NCT01180634MP-376 (Aeroquin™, Levofloxacin for Inhalation) in Patients With Cystic FibrosisCOMPLETEDPHASE32010-11-042012-05-072012-05-07
NCT01207388Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL)COMPLETEDPHASE22010-112019-01-072014-02
NCT01204749TRINOVA-1: A Study of AMG 386 or Placebo, in Combination With Weekly Paclitaxel Chemotherapy, as Treatment for Ovarian Cancer, Primary Peritoneal Cancer and Fallopian Tube CancerCOMPLETEDPHASE32010-112016-122013-03
NCT01253681Study of AMG 386 in Combination With Paclitaxel and Carboplatin in Subjects With Ovarian CancerCOMPLETEDPHASE12010-112015-012012-10
NCT01221727The Effects of Denosumab on the Pharmacokinetics (PK) of MidazolamCOMPLETEDPHASE12010-112011-072011-07
NCT01257737To Evaluate the Safety of Long-term Use of HPN-100 in the Management of Urea Cycle Disorders (UCDs)COMPLETEDPHASE42010-10-042017-02-162017-02-16
NCT01199289A Study to Evaluate the Dosing of AMG 827 for Subjects With Inadequately Controlled AsthmaCOMPLETEDPHASE22010-10-042011-12-212011-12-21
NCT01300208To Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus ErythematosusCOMPLETEDPHASE22010-10-012013-03-012013-01-01
NCT01181531Compare the Efficacy of Cinacalcet vs Traditional Vitamin D for Secondary Hyperparathyroidism (SHPT) Among Subjects Undergoing HemodialysisCOMPLETEDPHASE42010-10-012012-08-142012-07-17
NCT01209286Study of the BiTE® Blinatumomab (MT103) in Adult Patients With Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (ALL)COMPLETEDPHASE22010-102016-102012-03
NCT01212770PALACE 3: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic ArthritisCOMPLETEDPHASE32010-09-302017-02-092012-08-21
NCT01212757PALACE 2: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic ArthritisCOMPLETEDPHASE32010-09-272017-01-252012-07-26
NCT01194219Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque PsoriasisCOMPLETEDPHASE32010-09-092016-11-222012-02-23
NCT01242917A Study to Evaluate the Safety and Efficacy of CCX354-C in Subjects With Rheumatoid Arthritis Partially Responsive to Methotrexate TherapyCOMPLETEDPHASE22010-092011-072011-07
NCT01302392A Study of Carfilzomib vs Best Supportive Care in Subjects With Relapsed and Refractory Multiple MyelomaCOMPLETEDPHASE32010-092015-092014-07
NCT01235442Evaluate Efficacy, and Safety of Topical Therapy and Etanercept in Subjects With Moderate to Severe Plaque PsoriasisCOMPLETEDPHASE32010-092011-122011-10
NCT01197378Long-Term Safety Follow-up Study of Cysteamine Bitartrate Delayed-release Capsules (RP103)COMPLETEDPHASE32010-08-272017-06-262017-06-26
NCT01164917Safety Study of AMG 811 in Subjects With Discoid Lupus ErythematosusTERMINATEDPHASE12010-082013-032012-09
NCT01080391Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple MyelomaCOMPLETEDPHASE32010-07-142017-12-052014-06-16
NCT01164904Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative ColitisTERMINATEDPHASE12010-072013-032013-01
NCT01081678Study To Assess FRacTure Healing With SclerosTin Antibody - HipCOMPLETEDPHASE22010-06-202013-05-102012-06-30
NCT01059448Safety and Efficacy of AMG 827 in Subjects With RATERMINATEDPHASE22010-06-032011-04-052011-04-05
NCT01077154Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE)TERMINATEDPHASE32010-06-022018-03-262017-08-31
NCT01172938Efficacy and Safety Study of Apremilast to Treat Active Psoriatic ArthritisCOMPLETEDPHASE32010-06-022016-10-272012-04-27
NCT01000961Phase 3 Study of Cysteamine Bitartrate Delayed-release (RP103) Compared to Cystagon® in Patients With CystinosisCOMPLETEDPHASE32010-062011-082011-06
NCT01133522Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Evolocumab (AMG 145) in Adults With Hyperlipidemia on Stable Doses of a StatinCOMPLETEDPHASE12010-06-012011-09-142011-09-14
NCT01101048An Ascending Multiple Dose Study Evaluating AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral DensityCOMPLETEDPHASE12010-062012-022012-02
NCT01137552A Phase 1 Dose Escalation Study of AMG 780 in Adult Subjects With Advanced Solid TumorsTERMINATEDPHASE12010-062014-042013-12
NCT01137565Safety, Tolerability, and Pharcodynamics of AMG 853 in Adolescents With AsthmaCOMPLETEDPHASE12010-062011-012011-01
NCT01101061A Single-dose Study Evaluating Romosozumab (AMG 785) in Healthy Postmenopausal Japanese and Non-Japanese WomenCOMPLETEDPHASE12010-05-032010-11-012010-11-01
NCT01135680Double-Blind Randomized Crossover Trial to Access Electrocardiogram Effects of HPN-100COMPLETEDPHASE12010-052010-092010-09
NCT01124279Single-dose, Pharmacokinetics of AMG 853 in Healthy Adult SubjectsCOMPLETEDPHASE12010-052010-102010-08
NCT00975104AMG 745 in Subjects With Age-associated Muscle LossWITHDRAWNPHASE22010-042011-082011-05
NCT01129349Phase 1 Study of Oprozomib Administered Orally in Patients With Advanced Refractory or Recurrent Solid TumorsCOMPLETEDPHASE12010-042013-032012-11
NCT00975221Efficacy and Safety Study of Cinacalcet for the Treatment of Hypercalcemia in Patients With Primary Hyperparathyroidism Unable to Undergo ParathyroidectomyCOMPLETEDPHASE32010-03-102012-12-212012-07-12
NCT00947544Study of the Safety and Tolerability of HPN-100 Compared to Sodium Phenylbutyrate in Children With Urea Cycle DisordersCOMPLETEDPHASE22010-032011-082011-08
NCT01001377ASPECCT: A Study of Panitumumab Efficacy and Safety Compared to Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal CancerCOMPLETEDPHASE32010-02-022017-03-072013-02-05
NCT01028963A Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Type 2 Diabetes MellitusCOMPLETEDPHASE22010-012010-112010-10
NCT00950989Brodalumab (AMG 827) in Rheumatoid Arthritis (RA) Participants With Inadequate Response to MethotrexateCOMPLETEDPHASE22009-12-302011-02-112011-02-11
NCT01071954A Study Evaluating the Safety and Efficacy of Long-term Dosing of Romiplostim in Thrombocytopenic Pediatric Patients With Immune (Idiopathic) Thrombocytopenia PurpuraCOMPLETEDPHASE32009-12-302017-01-122017-01-12
NCT05984251A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CCX168 in Healthy ParticipantsCOMPLETEDPHASE12009-12-212011-04-112010-09-19
NCT00975000Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant RecipientsCOMPLETEDPHASE32009-12-032013-04-162012-09-13
NCT01027728Study to Evaluate Safety and Efficacy of CCX 354-C in Subjects With Rheumatoid ArthritisCOMPLETEDPHASE1, PHASE22009-122010-072010-07
NCT00999167A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic EncephalopathyCOMPLETEDPHASE22009-122012-042012-04
NCT00925600Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone LossCOMPLETEDPHASE32009-11-302016-05-122016-05-12
NCT00896454Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum CalciumCOMPLETEDPHASE22009-11-162013-08-212012-09-13
NCT00911170PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation StudyCOMPLETEDPHASE32009-11-032015-01-022012-09-17
NCT00947297Study of the Safety of HPN (Hyperion)-100 for the Long-Term Treatment of Urea Cycle Disorders (Treat UCD)COMPLETEDPHASE32009-112011-112011-09
NCT01001208The Efficacy and Safety of Adding Methotrexate to Etanercept in PsoriasisCOMPLETEDPHASE32009-112011-022010-12
NCT00992459Efficacy and Safety of HPN-100 for the Treatment of Adults With Urea Cycle DisordersCOMPLETEDPHASE32009-102010-092010-09
NCT00980174Study to Compare the Efficacy and Safety of DenosumAb Versus Placebo in Males With OsteoporosisCOMPLETEDPHASE32009-10-012012-05-232011-06-21
NCT01018550AMG 853 Phase 2 Study in Subjects With Inadequately Controlled AsthmaCOMPLETEDPHASE22009-102011-032010-12
NCT00972179Safety Study of Tezepelumab (AMG 157) in Healthy AdultsCOMPLETEDPHASE12009-09-152011-01-092011-01-09
NCT00907296Study of Romosozumab (AMG 785) in Tibial Diaphyseal Fractures Status Post Intramedullary NailingCOMPLETEDPHASE22009-09-022013-05-102012-03-06
NCT00984815Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug TreatmentCOMPLETEDPHASE32009-092011-072011-07
NCT00919711Study to Evaluate the Safety and Efficacy of Denosumab and Actonel® in Post Menopausal Women Transitioned From Alendronate TherapyCOMPLETEDPHASE32009-09-012012-03-052011-12-21
NCT00950950A Study to Evaluate the Effect of Romosozumab (AMG 785) on Bone Quality of the Forearm in Postmenopausal Women With Low Bone MassCOMPLETEDPHASE12009-08-182010-08-192010-08-19
NCT00907478Study on Bone Marrow Morphology in Adults Receiving Romiplostim for Treatment of Thrombocytopenia Associated With Immune Thrombocytopenia Purpura (ITP)COMPLETEDPHASE42009-08-112014-01-142014-01-09
NCT00858377A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid TumorsCOMPLETEDPHASE12009-08-102019-04-032014-12-31
NCT00866359A Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in the Treatment of Behçet DiseaseCOMPLETEDPHASE22009-08-012012-05-012012-05-01
NCT00872014A Study of the Effectiveness and Safety of AMG 386 and Sorafenib to Treat Advanced or Inoperable Hepatocellular CancerCOMPLETEDPHASE22009-082015-062011-10
NCT00858364Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving ChemotherapyTERMINATEDPHASE32009-07-172017-06-072017-06-07
NCT00890981A High-resolution Peripheral Quantitative Computed Tomography Study in Postmenopausal Women Previously Treated With DenosumabCOMPLETEDPHASE32009-072010-082010-06
NCT00950911Open Label Extension to SRE Studies in United Kingdom and Czech Republic OnlyCOMPLETEDPHASE32009-072012-042012-02
NCT00936897A Study to Evaluate the Safety and Efficacy of Denosumab and Ibandronate in Postmenopausal Women Sub-Optimally Treated With Daily or Weekly BisphosphonatesCOMPLETEDPHASE32009-072012-012011-11
NCT00896532Romosozumab (AMG 785) in Postmenopausal Women With Low Bone Mineral DensityCOMPLETEDPHASE22009-06-032016-02-182011-02-21
NCT00925587Evaluation of Monthly Darbepoetin Alfa Dosing for Correction of Anemia in Non-dialysis Chronic Kidney DiseaseCOMPLETEDPHASE32009-062012-052012-04
NCT00887965A Transiliac Crest Bone Histology and Histomorphometry Study in Postmenopausal Women With Low Bone Mass or Osteoporosis Previously Treated With DenosumabCOMPLETEDPHASE22009-062010-082010-06
NCT00853372AMG 386 Phase 2 Open-Label Renal Cell Carcinoma (RCC) Study 1st Line or After Cytokine Failure in Combination With SunitinibCOMPLETEDPHASE22009-05-282019-06-252011-08-08
NCT00872729Pilot Study of Safety, Tolerability, Pharmacokinetics/Pharmacodynamics of RP103 Compared to Cystagon® in Patients With CystinosisCOMPLETEDPHASE1, PHASE22009-052009-102009-10
NCT01386866Single Dose Study of [14C]-Labelled AMG 706 in Patients With Advanced Solid TumorsCOMPLETEDPHASE12009-052010-122010-11
NCT00902356A First-in-human Study Evaluating AMG 167 in Healthy Men and Postmenopausal WomenCOMPLETEDPHASE12009-052009-112009-11
NCT00819780PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) TumorsCOMPLETEDPHASE22009-04-242016-07-072012-05-30
NCT00884312A Study of Extended Carfilzomib Therapy for Patients Previously Enrolled in Carfilzomib Treatment ProtocolsCOMPLETEDPHASE22009-04-092017-05-172017-05-17
NCT00840333"Safety, Tolerability and Pharmacokinetics of MP-376 Administered for 14 Days to Stable Pediatric (CF) Patients"COMPLETEDPHASE12009-042009-122009-12
NCT00807859Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast CancerCOMPLETEDPHASE12009-03-092015-10-192014-02-27
NCT00818948Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without GlomerulonephritisCOMPLETEDPHASE12009-032014-082014-06
NCT00866944Study of Adecatumumab Relative to FOLFOX After R0 Resection of Colorectal Liver MetastasesCOMPLETEDPHASE22009-032011-112011-07
NCT0080371220070360 Incident DialysisCOMPLETEDPHASE42009-02-012011-07-052010-12-09
NCT00838201Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate CancerCOMPLETEDPHASE32009-02-012012-05-032012-05-03
NCT00719550AMG 102 Plus ECX for Unresectable Locally Advanced or Metastatic Gastric or Esophagogastric Junction CancerCOMPLETEDPHASE1, PHASE22009-022013-062010-11
NCT00770536AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CRCOMPLETEDPHASE12009-012015-062012-01
NCT00813384A Phase 1 Study of AMG 208 in Subjects With Advanced Solid TumorsCOMPLETEDPHASE12008-122014-122013-02
NCT00774943A Study of AMG 557 in Adults With Systemic Lupus ErythematosusCOMPLETEDPHASE12008-122012-052012-05
NCT00721734Study of the Safety and Pharmacokinetics of Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal FunctionCOMPLETEDPHASE22008-112012-112012-11
NCT00752570A Phase 2, Randomized, Double Blind, Placebo Controlled Study of AMG 386 in Combination With FOLFIRI in Subjects With Previously Treated Metastatic Colorectal CarcinomaCOMPLETEDPHASE22008-112012-062010-09
NCT00770848AMG 102 in Combination With Mitoxantrone and Prednisone in Subjects With Previously Treated Castrate Resistant Prostate CancerCOMPLETEDPHASE1, PHASE22008-112012-042011-01
NCT00771030Study to Evaluate the Safety, PK, PD and Efficacy of AMG 827 in Adults With Rheumatoid ArthritisCOMPLETEDPHASE1, PHASE22008-10-272010-05-252010-05-25
NCT00756444A Randomized Phase 2 Pharmacokinetic Trial of Chemotherapy With or Without Panitumumab in Patients With Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and NeckCOMPLETEDPHASE22008-10-212012-03-302012-03-30
NCT00739648A Phase 2 Study of MP-376 to Prevent Acute Exacerbations in Chronic Obstructive Pulmonary Disease (COPD) PatientsCOMPLETEDPHASE22008-102010-042010-01
NCT00791765Moderate to Severe Plaque Psoriasis With Scalp InvolvementCOMPLETEDPHASE42008-102010-032010-01
NCT00757042Safety Study of Tezepelumab (AMG 157) in Healthy Adults and Adults With Atopic DermatitisCOMPLETEDPHASE12008-09-182011-01-052011-01-05
NCT00436748Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Patients With Chronic Kidney DiseaseTERMINATEDPHASE32008-09-162014-03-032014-03-03
NCT00680992Study of Denosumab in Subjects With Giant Cell Tumor of BoneCOMPLETEDPHASE22008-09-092018-05-172018-05-17
NCT00773734Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)COMPLETEDPHASE22008-09-012015-05-202009-08-01
NCT00614523Romiplostim Treatment of Thrombocytopenia in Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)COMPLETEDPHASE22008-07-212015-11-302011-03-31
NCT00752414A Phase 1b Study to Evaluate the Safety and PK of MP-376 in Chronic Obstructive Pulmonary Disease (COPD) PatientsCOMPLETEDPHASE12008-072008-102008-10
NCT00677365Safety, Tolerability and Efficacy of MP-376 Given for 28 Days to Cystic Fibrosis (CF) PatientsCOMPLETEDPHASE22008-062009-062009-06
NCT00686335A New Modified-release Tablet Formulation of Prednisone (Lodotra®) in Patients With Nocturnal AsthmaCOMPLETEDPHASE22008-062010-052010-03
NCT00661921A Randomized Double Blind, Placebo Controlled Trial With AMG 108 in Patients With Type 2 Diabetes MellitusWITHDRAWNPHASE22008-062009-102009-06
NCT00654368CAMEO: Canadian Methotrexate and Etanercept Outcome StudyCOMPLETEDPHASE42008-062013-022012-12
NCT00603447Phase 1b Multicenter Study of Carfilzomib With Lenalidomide and Dexamethasone in Relapsed Multiple MyelomaCOMPLETEDPHASE12008-052016-012013-05
NCT00756860A Phase 1 Multiple Dose Study to Compare the Effects of AMG 223 and Sevelamer HCL (Renagel®)COMPLETEDPHASE12008-052009-092008-08
NCT00661141Phase IIa Study of Fomepizole for Acetaldehyde Toxicity After Ethanol Exposure in Subjects With Altered Ethanol MetabolismCOMPLETEDPHASE22008-042008-062008-06
NCT00650078Study to Assess the Safety and Efficacy of Modified-Release Prednisone (Lodotra®) Therapy in Patients With Active Rheumatoid ArthritisCOMPLETEDPHASE32008-032009-052009-05
NCT00658658Panitumumab in Children With Solid TumorsCOMPLETEDPHASE12008-032015-032015-03
NCT00563316Effect of Panitumumab on the Pharmacokinetics of IrinotecanCOMPLETEDPHASE12008-032010-062009-03
NCT00530114Study to Assess Fixed Dosing of AMG 223 in Subjects With Chronic Kidney Disease on Hemodialysis With HyperphosphatemiaCOMPLETEDPHASE22008-032009-022008-11
NCT00635596Phase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian CancerCOMPLETEDPHASE12008-032015-012014-01
NCT00791011Phase 1b Lymphoma Study of AMG 655 in Combination With Bortezomib or VorinostatCOMPLETEDPHASE12008-022011-082010-07
NCT00534027A Phase 1b/2 Study of AMG 655 in Combination With Paclitaxel and Carboplatin for the First-Line Treatment of Advanced Non-Small Cell Lung CancerCOMPLETEDPHASE1, PHASE22008-012011-032011-03
NCT00560794Phase II Study of the BiTE® Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL)COMPLETEDPHASE22008-012014-112009-09
NCT00630786Conatumumab/Panitumumab Combination Metastatic Colorectal Cancer StudyCOMPLETEDPHASE1, PHASE22008-012010-112009-05
NCT00597909Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic EncephalopathyTERMINATEDPHASE22007-122008-092008-09
NCT02291588A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects With Systemic Lupus ErythematosusCOMPLETEDPHASE12007-122010-062010-03
NCT00583674Phase 2 Study of AMG 386 (20060439) in Combination With Cisplatin & Capecitabine in Subjects With Metastatic Gastric, Gastroesophageal Junction, or Distal Esophageal AdenocarcinomaCOMPLETEDPHASE22007-122012-062010-03
NCT01825785A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Romosozumab (AMG 785)COMPLETEDPHASE12007-11-142008-12-022008-12-02
NCT00547157Radiotherapy Plus Panitumumab Compared to Chemoradiotherapy With Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and NeckCOMPLETEDPHASE22007-112012-032011-12
NCT00626704Phase 1b/2 Study of AMG 655 With Doxorubicin for the First-Line Treatment of Unresectable Soft Tissue SarcomaCOMPLETEDPHASE1, PHASE22007-112011-032009-08
NCT00446446PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer)COMPLETEDPHASE22007-10-302017-11-292010-12-15
NCT00540657A Phase II Study of CCX282-B in Patients With Celiac DiseaseCOMPLETEDPHASE22007-102008-072008-06
NCT00551200Dose-Escalation Safety Study of HPN-100 to Treat Urea Cycle DisordersCOMPLETEDPHASE22007-102008-122008-07
NCT00603642P3 Study to Evaluate Efficacy and Safety of AMG 531 in Thrombocytopenic Japanese Subjects With Immune (Idiopathic) Thrombocytopenic PurpuraCOMPLETEDPHASE32007-10-012009-04-132009-04-13
NCT00500760Study of Addition of Panitumumab to Chemoradiation Therapy in Patients With Locally Advanced Head and Neck CancerCOMPLETEDPHASE22007-10-012011-04-262011-03-29
NCT00625651Phase 1b/2 Study of AMG 655 With mFOLFOX6 and Bevacizumab for First-Line Metastatic Colorectal CancerCOMPLETEDPHASE1, PHASE22007-102011-092010-08
NCT00613106Double-Blind Follow-on Safety Study of HZT-501 (Ibuprofen 800 mg/Famotidine 26.6 mg) in Subjects Who Have Completed Participation in HZ-CA-301 (NCT00450658) or HZ-CA-303 (NCT00450216)COMPLETEDPHASE32007-092008-102008-10
NCT00518531Denosumab Adherence Preference Satisfaction StudyCOMPLETEDPHASE32007-09-012010-06-012009-06-01
NCT00531284Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or LymphomaCOMPLETEDPHASE1, PHASE22007-092017-05-222014-10
NCT00530816Phase 2 Study of Carfilzomib in Relapsed Multiple MyelomaCOMPLETEDPHASE22007-092013-072013-01
NCT00523341Extension Study to Evaluate the Long Term Safety and Efficacy of Denosumab in the Treatment of OsteoporosisCOMPLETEDPHASE32007-08-072015-07-192015-07-19
NCT00521339Apremilast Safety and PK Study in Recalcitrant Plaque PsoriasisCOMPLETEDPHASE22007-08-012009-05-012009-04-01
NCT00511238Phase 2 Study of Carfilzomib in Relapsed and Refractory Multiple MyelomaCOMPLETEDPHASE22007-082012-102010-11
NCT00479817Phase 2 AMG 386 in Comb. Paclitaxel for Subjects With Advanced Recurrent Epithelial Ovarian or Primary Peritoneal CancerCOMPLETEDPHASE22007-07-052019-12-092009-08-11
NCT00511459Phase 2 Study of AMG 386 Plus Paclitaxel With or Without Bevacizumab as First Line Therapy in Her2-Negative Breast Cancer PatientsCOMPLETEDPHASE22007-072014-052010-08
NCT00460317MONET1-MOtesanib NSCLC Efficacy and Tolerability StudyTERMINATEDPHASE32007-072013-082011-03
NCT00515203Safety and Efficacy Study of Romiplostim (AMG 531) to Treat ITP in Pediatric SubjectsCOMPLETEDPHASE1, PHASE22007-072009-082009-03
NCT00503490Safety, Pharmacokinetic and Pharmacodynamic Study of MP-376 in Patients With Cystic FibrosisCOMPLETEDPHASE12007-062007-122007-12
NCT00508404Panitumumab Plus FOLFIRI in First-line Treatment of Metastatic Colorectal CancerCOMPLETEDPHASE22007-05-092012-06-122009-06-01
NCT00467025AMG 386, 20060159 Phase 2, RCC 1st Line in Combination With SorafenibCOMPLETEDPHASE22007-052014-062010-04
NCT00460265Study of Panitumumab Efficacy in Patients With Recurrent and/or Metastatic Head and Neck CancerCOMPLETEDPHASE32007-052012-052010-05
NCT00515463A Multi-Center, Randomized, Open-Label Study to Assess the Immunogenicity and Safety of Denosumab in Pre-filled Syringe Compared to Vial in Subjects With Low Bone Mineral DensityCOMPLETEDPHASE32007-052009-032008-03
NCT00472290Evaluating the Safety of Long Term Dosing of Romiplostim (Formerly AMG 531) in Thrombocytopenic Subjects With Myelodysplastic Syndromes (MDS)COMPLETEDNA2007-04-012011-12-262011-07-18
NCT00456092Phase II Study of Apremilast (CC-10004) in Adults With in Psoriatic ArthritisCOMPLETEDPHASE22007-03-052009-05-092009-05-09
NCT00450216Efficacy and Safety Study of HZT-501 in Subjects Requiring Nonsteroidal Anti-Inflammatory Drug (NSAID) TreatmentCOMPLETEDPHASE32007-032008-102008-08
NCT00450658Efficacy and Safety Study of HZT-501 in Reducing the Risk of Ibuprofen-associated UlcersCOMPLETEDPHASE32007-032008-102008-09
NCT00436670Phase II Study to Evaluate the Efficacy of AMG 317COMPLETEDPHASE22007-032009-022008-09
NCT00443326AMG 714 20060349 Multiple Dose Study in Moderate to Severe Psoriasis SubjectsCOMPLETEDPHASE22007-032010-052008-12
NCT00448786Effect of Different Doses of AMG 706 on the Gallbladder in Advanced Solid TumorsCOMPLETEDPHASE12007-022009-032008-12
NCT00369070A Phase 2 Trial of AMG 706 or Bevacizumab in Combination With Chemo for Advanced NSCLCTERMINATEDPHASE22007-01-312011-08-032008-04-23
NCT00454779PARTNER: Panitumumab Added to Regimen for Treatment of Head aNd Neck Cancer Evaluation of ResponseCOMPLETEDPHASE22007-01-012014-01-012012-06-11
NCT00422019A Phase II Study to Treat Subjects With Advanced Renal Cell CarcinomaCOMPLETEDPHASE22007-012009-032009-03
NCT00613730Adenocarcinoma of the Pancreas Treated With Panitumumab and Gemcitabine Regimen to Investigate Overall Survival as Primary EndpointTERMINATEDPHASE22007-012009-042009-04
NCT00534456An Exploratory Sub-study for the RED-HF™ (Reduction of Events With Darbepoetin Alfa in Heart Failure) TrialTERMINATEDPHASE32007-012007-102007-10
NCT00556374Study to Determine Treatment Effects of Denosumab in Patients With Breast Cancer Receiving Aromatase Inhibitor TherapyCOMPLETEDPHASE32006-12-182022-07-262014-10-07
NCT01059435A First-in-human Study Evaluating Romosozumab (AMG 785) in Healthy Men and Postmenopausal WomenCOMPLETEDPHASE12006-12-132007-07-062007-07-06
NCT00415532Romiplostim (AMG 531) Versus Medical Standard of Care for Immune (Idiopathic) Thrombocytopenic PurpuraCOMPLETEDPHASE32006-12-012009-05-112008-11-07
NCT00356681A Study of AMG 706 or Bevacizumab, in Combination With Paclitaxel Chemotherapy, as Treatment for Breast CancerTERMINATEDPHASE22006-122012-082009-02
NCT02318407A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 403 in Subjects With Osteoarthritis Knee PainCOMPLETEDPHASE12006-122008-032008-01
NCT00401544Darbepoetin Alfa With or Without Intravenous (IV) IronCOMPLETEDPHASE22006-122008-032007-12
NCT00413283Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC)COMPLETEDPHASE22006-122009-022008-12
NCT00418665A Safety and Efficacy Study to Evaluate AMG 531 Treatment in Subject With Myelodysplastic Syndrome Receiving RevlimidCOMPLETEDPHASE22006-122010-102009-03
NCT00413452Etanercept SFP in RA PatientsCOMPLETEDPHASE32006-122007-102007-08
NCT00418938SPIRITT - Second-Line Panitumumab Irinotecan Treatment TrialCOMPLETEDPHASE22006-11-012013-04-012012-05-10
NCT00411450Panitumumab Regimen Evaluation in Colorectal Cancer to Estimate Primary Response to TreatmentCOMPLETEDPHASE22006-112010-102009-01
NCT00427440A Phase II Study to Treat Advanced Malignant GliomaCOMPLETEDPHASE22006-112013-042008-12
NCT02391259A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus ErythematosusCOMPLETEDPHASE12006-112011-112011-09
NCT00321711Determination of Safe and Effective Dose of Romiplostim (AMG 531) in Subjects With Myelodysplastic Syndrome (MDS)Receiving Hypomethylating AgentsCOMPLETEDPHASE22006-10-012009-10-192009-10-19
NCT00986895A Study of Glyceryl Tri-(4-phenylbutyrate) Administered Orally as a Single Dose, and Twice Daily for Seven Consecutive Days to Subjects With Hepatic Impairment With Cirrhosis and to a Control GroupCOMPLETEDPHASE12006-092007-06
NCT00369473Long-Term Assessment of Safety and Physical Function With AMG 108 in RACOMPLETEDPHASE22006-092008-062008-06
NCT00379899ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving HemodialysisCOMPLETEDPHASE42006-092009-112009-05
NCT00364845STIMULATE Study: Anemia Correction and Health-related Quality of Life (HRQoL) Outcomes in Elderly Chronic Kidney Disease (CKD) PatientsTERMINATEDPHASE32006-092009-022008-12
NCT00361634Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Measure Response to Etanercept in Rheumatoid ArthritisCOMPLETEDPHASE12006-092010-032009-08
NCT00431496A Study of Cinacalcet to Improve Achievement of National Kidney Foundation Kidney Disease Outcomes Quality Initiative (K/DOQI) Targets in Patients With End Stage Renal Disease (ESRD)COMPLETEDPHASE42006-092009-102009-06
NCT00377819Study of Transitioning From Alendronate to DenosumabCOMPLETEDPHASE32006-092008-072008-03
NCT00345839E.V.O.L.V.E. Trial™: EValuation Of Cinacalcet Hydrochloride (HCl) Therapy to Lower CardioVascular EventsCOMPLETEDPHASE32006-08-222012-04-102012-04-10
NCT00364013PRIME: Panitumumab Randomized Trial In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine EfficacyCOMPLETEDPHASE32006-08-012013-03-222009-08-01
NCT00396279Safety and Efficacy Study of Denosumab in Patients With Recurrent or Unresectable Giant Cell Tumor of BoneCOMPLETEDPHASE22006-07-102011-02-012008-04-07
NCT00339183Comparison of Treatment Effect of Chemotherapy With Panitumumab to Chemotherapy AloneCOMPLETEDPHASE32006-06-302010-11-012009-04-01
NCT00330759Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma.COMPLETEDPHASE32006-06-012011-10-012009-04-01
NCT00358215RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure TrialCOMPLETEDPHASE32006-06-012012-10-112012-10-11
NCT00508625A Study of AMG 951 [rhApo2L/TRAIL] in Subjects With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) Treated With Chemotherapy +/- BevacizumabCOMPLETEDPHASE22006-062011-112009-03
NCT00325468An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety of Denosumab Administration in Postmenopausal Women With Low Bone Mineral DensityCOMPLETEDPHASE32006-05-012012-08-022011-03-28
NCT00293813A Multicenter, Randomized Placebo Controlled Pilot MicroCT Study to Estimate the Effect of Treatment With Denosumab (AMG 162) and Alendronate Sodium in Postmenopausal Women With Low Bone Mineral DensityCOMPLETEDPHASE22006-052008-082008-03
NCT00261950Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal DiseaseCOMPLETEDPHASE22006-052011-052011-05
NCT00330460A Randomized, Double-Blind Study to Compare the Efficacy of Treatment With Denosumab Versus Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density.COMPLETEDPHASE32006-052008-012007-11
NCT00321464A Study Comparing Denosumab vs. Zoledronic Acid for the Treatment of Bone Metastases in Breast Cancer Subjects.COMPLETEDPHASE32006-04-012012-04-042009-07-20
NCT00606450Double-Blind, Randomized, Placebo-controlled Comparison of CC-10004 in Subjects With Moderate to Severe Plaque Type PsoriasisCOMPLETEDPHASE22006-04-012007-05-012007-02-01
NCT00321620Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Men With Hormone-refractory Prostate CancerCOMPLETEDPHASE32006-04-012012-02-242009-10-01
NCT00332163Skin Toxicity Treatment in Metastatic Colorectal Cancer (mCRC) Patients Receiving Panitumumab + Irinotecan-based TherapyCOMPLETEDPHASE22006-042008-092008-01
NCT00436995Extension From Weekly to Once Every Other Week Darbepoetin Alfa Administration in Subjects With Chronic Kidney Disease Receiving DialysisCOMPLETEDPHASE32006-042008-122007-01
NCT00327119Phase 2 Study of ABX-EGF (Panitumumab) in Japanese Subjects With M-colorectal CancerCOMPLETEDPHASE22006-04
NCT00306215A Study to Evaluate the Efficacy and Safety of CCX282-B in Subjects With Moderate to Severe Crohn's DiseaseCOMPLETEDPHASE22006-032009-062008-08
NCT00352950Safety Evaluation of Panitumumab and Sirolimus in Advanced Non-Small Cell Lung CancerWITHDRAWNPHASE12006-032008-02
NCT00332332Canadian Assessment of Patient Outcomes and Effectiveness of Etanercept (Enbrel) in PsoriasisCOMPLETEDPHASE42006-032010-022009-07
NCT00322400Phase1b to Evaluate Safety of AMG706 in Combination With Paclitaxel or Docetaxel for Breast CancerCOMPLETEDPHASE12006-032012-012009-04
NCT00293826A Multiple Dose Study to Evaluate Subcutaneous AMG 108 in Subjects With Rheumatoid ArthritisCOMPLETEDPHASE22006-032008-022007-11
NCT00303472Determination of Safe Dose of Romiplostim (AMG 531) in Patients With Myelodysplastic Syndromes (MDS)COMPLETEDPHASE22006-022008-052008-05
NCT00286091Study on Prolonging Bone Metastasis-Free Survival in Men With Hormone Refractory Prostate CancerCOMPLETEDPHASE32006-01-242014-04-092010-07-30
NCT00346294An Open-Label Study to Assess the Rate of Failure of an Enbrel® (Etanercept) SureClick™ Auto-injector in Subjects With Rheumatoid ArthritisCOMPLETEDPHASE42006-012006-072006-03
NCT00306189A Randomized, Double-blind, Placebo-controlled, Dose Response Study of AMG 162 (Denosumab) in Japanese Postmenopausal Osteoporotic SubjectsCOMPLETEDPHASE22006-012007-112007-06
NCT00861419To Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 386 When Used in Combination With AMG 706, Bevacizumab, Sorafenib, or Sunitinib.COMPLETEDPHASE12005-12
NCT00360867An Open Label Treatment Extension Study of AMG 706TERMINATEDPHASE22005-122012-072012-07
NCT00261313ACCELERATE: Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Pegfilgrastim and Darbepoetin Alfa Support for the Treatment of Women With Breast CancerCOMPLETEDPHASE22005-122007-122007-06
NCT00259740Open-Label, Phase 2, Proof of Concept Study in Multiple Myeloma - DenosumabCOMPLETEDPHASE22005-112011-122007-08
NCT00254267Evaluate the Efficacy of AMG 706 to Treat Advanced Gastrointestinal Stromal TumorsCOMPLETEDPHASE22005-112012-122007-02
NCT00283439A Dose and Schedule Finding Trial With AMG 531 for Chemotherapy Induced Thrombocytopenia (CIT) in Adults With LymphomaCOMPLETEDPHASE1, PHASE22005-102008-092008-05
NCT00249041Enbrel Liquid Immunogenicity ProtocolCOMPLETEDPHASE32005-102007-032006-12
NCT00150462Safety Study of the Proteasome Inhibitor PR-171 (Carfilzomib for Injection) in Patients With Hematological MalignanciesCOMPLETEDPHASE12005-092009-102009-10
NCT01235416A Phase 1b, Open-label, Dose-finding Study of AMG 706 in Combination With Gemcitabine and Erlotinib to Treat Subjects With Solid TumorsCOMPLETEDPHASE12005-092010-022008-04
NCT00146224Efficacy of Epoetin Alfa Deep Tank in Treatment of Anemia in Patients With Chronic Kidney Disease Receiving HemodialysisCOMPLETEDPHASE32005-092007-012007-01
NCT00141921Pediatric Open-Label Extension Study of Etanercept in Patients With Plaque PsoriasisCOMPLETEDPHASE32005-08-112017-08-162011-12-19
NCT00393822A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Stage 2B or 3 Locally Advanced, Colon CancerCOMPLETEDPHASE2, PHASE32005-082014-032007-12
NCT00127842REPArE: Rating Evaluations in Psoriatic Arthritis (PsA) With Etanercept (Enbrel®)COMPLETEDPHASE42005-082009-092005-08
NCT00135304ACHIEVE: Optimizing the Treatment of Secondary HyperparathyroidismCOMPLETEDPHASE42005-082006-122006-10
NCT00144131Flexibility: A Study to Assess the Impact of Darbepoetin Alfa in Subjects withNon-Myeloid Malignancies With Anemia Due to ChemotherapyCOMPLETEDPHASE22005-08
NCT00239239Fractionated Dosing Study: Study to Evaluate Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid MalignanciesCOMPLETEDPHASE22005-082007-032007-01
NCT00121628A Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced or Metastatic Thyroid CancerCOMPLETEDPHASE22005-072010-102006-11
NCT00115765PACCE: Panitumumab Advanced Colorectal Cancer Evaluation StudyCOMPLETEDPHASE32005-06-012009-05-012007-05-31
NCT02411136A Study to Examine the Safety, Pharmacokinetics and Pharmacodynamics of AMG 623 in Subjects With Systemic Lupus ErythematosusCOMPLETEDPHASE12005-052007-102007-08
NCT00115219Evaluating Efficacy and Safety of Etanercept 50 mg Twice Weekly (BIW) in Rheumatoid Arthritis (RA) Subjects Who Are Sub-Optimal Responders to Etanercept 50 mg Once Weekly (QW)COMPLETEDPHASE42005-05
NCT00116701Treatment for Subjects With Chronic Kidney Disease Receiving HaemodialysisCOMPLETEDPHASE32005-05
NCT00102336AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Prior to SplenectomyCOMPLETEDPHASE32005-04-072007-04-012006-12-01
NCT00156949EPO Deep Tank in Dialysis SubjectsCOMPLETEDPHASE32005-042007-022007-02
NCT00156962Epoetin Alfa (EPO) in Subjects With Chronic Kidney Disease (CKD)TERMINATEDPHASE32005-042007-032007-03
NCT00102323AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to SplenectomyCOMPLETEDPHASE32005-03-292007-03-012006-09-01
NCT00977600A Study of Glyceryl Tri-(4-phenylbutyrate) (GT4P)COMPLETEDPHASE12005-032005-07
NCT00110981Utilization of Narrow Band Ultraviolet B (UVB) Light Therapy and Etanercept for the Treatment of PsoriasisCOMPLETEDPHASE42005-032006-032006-02
NCT00121602Efficacy Study: Darbepoetin Alfa for the Treatment of Anemia in Patients With Chronic Kidney DiseaseCOMPLETEDPHASE32005-032006-102005-10
NCT00508820An Open Label Study of Romiplostim in Adult Thrombocytopenic Subjects With ITPCOMPLETEDPHASE32005-02-012011-03-012011-01-01
NCT00110942Treatment for Patients With Osteoarthritis (OA)COMPLETEDPHASE22005-022005-112005-06
NCT00604682Open-Label,Single-Arm Pilot Study to Evaluate the Pharmacodynamics, Pharmacokinetics, Safety, and Preliminary Efficacy of CC1004 in Subjects With Severe Plaque Type PsoriasisCOMPLETEDPHASE22005-01-012005-12-012005-10-01
NCT00131638A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Advanced Head and Neck CancerCOMPLETEDPHASE32005-012016-072007-11
NCT00094835Study to Evaluate Motesanib With or Without Carboplatin/Paclitaxel or Panitumumab in the Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)COMPLETEDPHASE1, PHASE22005-012007-032007-03
NCT02348879A Study to Examine the Safety, Pharmacokinetics and Pharmacodynamics of AMG 403 in Healthy SubjectCOMPLETEDPHASE12005-012006-032006-01
NCT00104650Study of AMG 162 in Subjects With Advanced Cancer Currently Being Treated With Intravenous (IV) BisphosphonatesCOMPLETEDPHASE22005-012010-032008-01
NCT00101907Safety of AMG 706 Plus Panitumumab Plus Gemcitabine-Cisplatin in the Treatment of Patients With Advanced CancerTERMINATEDPHASE12004-122008-042007-06
NCT00101894Safety of AMG 706 Plus Panitumumab Plus Chemotherapy in the Treatment of Subjects With Metastatic Colorectal CancerCOMPLETEDPHASE12004-122011-122010-04
NCT00135317AIM 3: Anemia and Iron Management With Every 3 Week Dosing in Anemic Subjects With Nonmyeloid MalignanciesCOMPLETEDPHASE32004-11
NCT00089661AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Aromatase Inhibitor Therapy for Non-metastatic Breast CancerCOMPLETEDPHASE32004-10-012009-05-272007-05-11
NCT02443506A Study to Examine the Safety, Pharmacokinetics and Pharmacodynamics of Single Dose of AMG 623 in Subjects With Systemic Lupus ErythematosusCOMPLETEDPHASE12004-102007-062007-04
NCT00093977Study to Assess Darbepoetin Alfa in Subjects With Chronic Kidney DiseaseCOMPLETEDPHASE32004-102007-012007-01
NCT00094484Cinacalcet HCl in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism Not Receiving DialysisCOMPLETEDPHASE32004-10
NCT00089960Study of AMG 706 in Subjects With Advanced Gastrointestinal Stromal Tumors (GISTs)COMPLETEDPHASE22004-102008-062006-06
NCT00095264A Study of Darbepoetin Alfa in Anemic Subjects With Low Risk Myelodysplastic SyndromeCOMPLETEDPHASE22004-10
NCT00096915Study Evaluating Darbepoetin Alfa in Subjects With Chronic Kidney Disease (CKD) Receiving DialysisCOMPLETEDPHASE32004-102005-112005-11
NCT00095277Darbepoetin Alfa Administered Once Every 4 Weeks in the Treatment of Subjects With Anemia of CancerCOMPLETEDPHASE22004-10
NCT00121615Study of Etanercept in the Treatment of Psoriasis in Adult SubjectsCOMPLETEDPHASE32004-10
NCT00094341Preference of Rheumatoid Arthritis (RA) Patients of Enbrel® (Etanercept) Auto-Injector Versus Enbrel® Pre-Filled SyringesCOMPLETEDPHASE42004-10
NCT00078819Etanercept (Enbrel®) in Psoriasis - PediatricsCOMPLETEDPHASE32004-09-082007-06-012006-02-01
NCT00091832Denosumab (AMG 162) in Bisphosphonate Naive Metastatic Breast CancerCOMPLETEDPHASE22004-092006-102005-11
NCT00117052SENSOR: Study to Investigate Cinacalcet Treatment in Haemodialysis Patients With Secondary HyperparathyroidismCOMPLETEDPHASE32004-092006-022005-11
NCT00095498Efficacy, Safety and Tolerability of Denosumab in the Treatment of Rheumatoid ArthritisCOMPLETEDPHASE22004-08-112007-04-012007-04-01
NCT00102921Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn's DiseaseCOMPLETEDPHASE22004-082005-12
NCT00089635Panitumumab (ABX-EGF) Monotherapy in Patients With Metastatic Colorectal CancerCOMPLETEDPHASE22004-08-012008-08-012007-01-01
NCT00089791A Study to Evaluate Denosumab in the Treatment of Postmenopausal OsteoporosisCOMPLETEDPHASE32004-08-012008-06-172008-06-17
NCT00093015Trial to Reduce Cardiovascular Events With Aranesp® Therapy (TREAT)COMPLETEDPHASE32004-08-012009-07-012009-03-01
NCT00089674AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-metastatic Prostate CancerCOMPLETEDPHASE32004-08-012010-05-112008-05-16
NCT02588534Open-label Study Using 50 Mg Liquid Etanercept Subcutaneous Injection in the Thigh to Compare an Auto-injector Device and a Manual Injection in Healthy SubjectsCOMPLETEDPHASE12004-082004-102004-10
NCT00116688Open Label Extension Study of Romiplostim (AMG 531) in Thrombocytopenic Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)COMPLETEDPHASE32004-082010-012010-01
NCT00091793Study to Evaluate AMG 162 in the Prevention of Postmenopausal OsteoporosisCOMPLETEDPHASE32004-082009-032009-02
NCT00091806Two Dose Schedules of Panitumumab in Subjects With Advanced Solid TumorsCOMPLETEDPHASE12004-082006-102006-04
NCT00115167A Study of Darbepoetin Alfa in Anemic Subjects Not Receiving Chemotherapy Who Have Completed the 20010103 StudyCOMPLETEDPHASE32004-082007-032007-01
NCT00132431START: Sensipar Treatment Algorithm to Reach K/DOQI Targets in Chronic Kidney Disease Subjects With Secondary HyperparathyroidismCOMPLETEDPHASE42004-072005-07
NCT00274742Safety Study of the Bispecific T-cell Engager Blinatumomab (MT103) in Patients With Relapsed NHLCOMPLETEDPHASE12004-062012-042011-08
NCT00110916Treatment for Patients With Osteoarthritis (OA) of the KneeCOMPLETEDPHASE22004-062005-022005-02
NCT00110890A Research Study for Patients With End-Stage Renal Disease (ESRD)COMPLETEDPHASE42004-052007-092005-04
NCT00125723FIRST - Study of Pegfilgrastim Administered in the First and Subsequent Cycles of Myelosuppressive ChemotherapyCOMPLETEDPHASE42004-052005-122005-12
NCT00099554Effectiveness and Safety of Enbrel® (Etanercept) in Rheumatoid Arthritis Subjects Who Have Failed Remicade® (Infliximab)COMPLETEDPHASE42004-05
NCT00112008Study for Subjects With Chronic Kidney Disease(CKD) Not Receiving DialysisCOMPLETEDPHASE32004-052005-032005-03
NCT00091858Study of Darbepoetin Alfa for the Treatment of Anemia of CancerCOMPLETEDPHASE32004-042006-122006-10
NCT00083616Evaluating Panitumumab (ABX-EGF) Monotherapy in Patients With Metastatic Colorectal Cancer Following Treatment With Fluoropyrimidine, Irinotecan, and Oxaliplatin ChemotherapyCOMPLETEDPHASE22004-032008-122007-05
NCT00118638A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle ChemotherapyCOMPLETEDPHASE32004-032005-012004-12
NCT00425204Study for Patients Who Have Benefited and Tolerated Prior Panitumumab TreatmentCOMPLETEDPHASE22004-032008-032007-09
NCT00111098Treatment for Subjects With Chronic Kidney Disease (CKD) Not Receiving DialysisCOMPLETEDPHASE32004-032005-112005-11
NCT00110955Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle ChemotherapyCOMPLETEDPHASE32004-022005-042005-03
NCT00113763Evaluating Panitumumab (ABX-EGF) Plus Best Supportive Care Versus Best Supportive Care in Patients With Metastatic Colorectal CancerCOMPLETEDPHASE32004-01-012009-06-012008-10-01
NCT00117039A Study to Evaluate the Effectiveness of Aranesp® for Cancer Patients With AnemiaCOMPLETEDPHASE42004-012005-04
NCT00111982Trial of Extended Treatment With Liatermin (r-metHuGDNF) Administered by Continuous Intraputaminal (IPu)Infusion to Subjects With Idiopathic Parkinson's Disease Who Have Completed a Previous Trial of LiaterminCOMPLETEDPHASE1, PHASE22003-122006-022005-11
NCT02799498Compare Actions in Healthy Volunteer of 50 mg Etanercept Injection Using an Auto-injector Device and Manual InjectionCOMPLETEDPHASE12003-102004-012004-01
NCT00113789Evaluating Pegfilgrastim and a Multi-Day Topotecan Regimen in Subjects With Relapsed or Refractory Ovarian CancerCOMPLETEDPHASE22003-102005-042005-04
NCT03822078Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Denosumab (AMG 162) in Japanese Postmenopausal WomenCOMPLETEDPHASE12003-09-302004-12-242004-12-24
NCT00086086Subcutaneous (SC) Darbepoetin Alfa in Subjects With Symptomatic Congestive Heart Failure (CHF) & AnemiaCOMPLETEDPHASE22003-08
NCT00093873Study Evaluating AMG 706 in Subjects With Advanced Solid TumorsCOMPLETEDPHASE12003-072006-122006-02
NCT00113945Research Study Evaluating Cinacalcet for Patients With End Stage Renal Disease (ESRD)COMPLETEDPHASE22003-07
NCT00111449Evaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects With PsoriasisCOMPLETEDPHASE32003-06
NCT00101920ABX-EGF as Second Line Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)COMPLETEDPHASE22003-062004-122004-12
NCT00111436Evaluating the Safety of Etanercept in the Treatment of Psoriasis in Adult SubjectsCOMPLETEDPHASE32003-042005-072005-07
NCT00066092Pegfilgrastim PBPC Mobilization StudyCOMPLETEDPHASE22003-042004-102004-03
NCT00114764Trial Comparing Pegfilgrastim With Filgrastim as an Adjunct to Chemotherapy for Acute Myeloid Leukaemia (AML)COMPLETEDPHASE22003-032004-082004-04
NCT00115427Study of Liatermin (r-metHuGDNF) Administered by Bilateral Intraputaminal (IPu) Infusion to Subjects With Idiopathic Parkinson's DiseaseCOMPLETEDPHASE12003-03
NCT00094809Chemotherapy Administered Every 2 Weeks With or Without Pegfilgrastim in Subjects With Advanced or Metastatic Colon CancerCOMPLETEDPHASE22003-02-012008-01-232006-05-19
NCT00115193Pegfilgrastim Administered on the Same Day as Chemotherapy in Non-Hodgkin's LymphomaCOMPLETEDPHASE22003-022005-082005-08
NCT00425035Safety and Efficacy Study of ABX-EGF in Patients With Renal Cancer, Part 2COMPLETEDPHASE22003-02
NCT00111137Treatment for Patients With Non-Myeloid Malignancies Receiving ChemotherapyCOMPLETEDPHASE32003-022004-042003-11
NCT00117143Amgen Megakaryopoiesis Protein 2 (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP)COMPLETEDPHASE1, PHASE22002-12-022004-07-192004-07-19
NCT00119613A Study of Subjects With Previously Untreated Extensive-Stage Small-Cell Lung Cancer (SCLC) Treated With Platinum Plus Etoposide Chemotherapy With or Without Darbepoetin AlfaCOMPLETEDPHASE32002-122007-042007-01
NCT00433875Phase 2 AMG 714 in Rheumatoid ArthritisCOMPLETEDPHASE22002-12
NCT00117624A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With a Non-Myeloid MalignancyCOMPLETEDPHASE32002-122003-12
NCT00110929Treatment for Patients With Secondary Hyperparathyroidism of End-Stage Renal Disease (ESRD)COMPLETEDPHASE22002-11
NCT00120705Treatment for Anemic Subjects With Non-Myeloid Malignancies Receiving ChemotherapyCOMPLETEDPHASE22002-112003-09
NCT00117910Treatment for Elderly Patients With High Risk Breast CancerCOMPLETEDPHASE32002-102004-05
NCT00120679Treatment for Patients With Non-Small Cell Lung Cancer Who Developed Anemia Due to ChemotherapyCOMPLETEDPHASE22002-102003-12
NCT00120692Treatment for Patients Suffering From Anemia Due to ChemotherapyCOMPLETEDPHASE22002-102003-12
NCT00121030Treatment for Patients With Gynecological Malignancies Who Suffer From Anemia Due to ChemotherapyCOMPLETEDPHASE22002-102003-12
NCT00117234Impact of Darbepoetin Alfa on Exercise Tolerance and Left Ventricular Structure in Subjects With Symptomatic Congestive Heart Failure (CHF) and AnemiaCOMPLETEDNA2002-092004-07
NCT00117117A Study to Assess Symptom Burden in Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Aranesp®COMPLETEDPHASE42002-092003-12
NCT00117442A Study of Carboplatin/Paclitaxel With Pegfilgrastim Supported by Haematopoietic Progenitor Cell Re-Infusion in Whole BloodCOMPLETEDPHASE22002-082004-122004-08
NCT00111423Evaluating the Safety of Extended Treatment With Pegsunercept (PEG sTNF-RI)in Subjects With Rheumatoid Arthritis (RA)COMPLETEDPHASE22002-08
NCT00119587Darbepoetin Alfa Treatment of Anemia in Hemodialysis SubjectsCOMPLETEDPHASE32002-082003-09
NCT00111475Evaluating the Safety and Efficacy of Romiplostim (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP)COMPLETEDPHASE22002-07-012004-06-172004-06-17
NCT00111761Evaluating Panitumumab (ABX-EGF) in Patients With Metastatic Colorectal CancerCOMPLETEDPHASE22002-072008-102008-02
NCT00049985Heart Failure and AnemiaCOMPLETEDPHASE22002-07
NCT00117897Treatment for Subjects With Non-Hodgkin's LymphomaCOMPLETEDPHASE22002-072004-02
NCT00115206Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During ChemotherapyCOMPLETEDPHASE42002-072004-07
NCT00042432Study for Secondary Hyperparathyroidism in Chronic Renal Insufficiency PatientsCOMPLETEDPHASE22002-062003-082003-03
NCT00277160A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With CancerCOMPLETEDPHASE42002-062005-012004-11
NCT00117247A Study of Repeat-Dose Subcutaneous Darbepoetin Alfa in Subjects With Congestive Heart Failure and Anemia, and a Single Dose in Healthy Age- and Sex-Matched Control SubjectsCOMPLETEDPHASE1, PHASE22002-062004-07
NCT00989092Darbepoetin Alfa and Anemia of CancerTERMINATEDPHASE22002-052004-062004-01
NCT00043186Determine the Efficacy, Safety and Tolerability of Denosumab (AMG 162) in the Treatment of Postmenopausal Women With Low Bone Mineral DensityCOMPLETEDPHASE22002-052007-062007-04
NCT00042653A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Patients on DialysisCOMPLETEDPHASE32002-052003-072003-07
NCT00369733STAAR-3 Clinical StudyCOMPLETEDPHASE42002-052004-052004-03
NCT00111995Evaluating Aranesp® for the Treatment of Anemia in African-American Subjects With Chronic Renal Failure (CRF) Receiving HemodialysisCOMPLETEDPHASE42002-05
NCT0035635616.0040 Ankylosing Spondylitis StudyCOMPLETEDPHASE32002-042006-092006-08
NCT00038298A Rheumatoid Arthritis (RA) Study Treating Signs and Symptoms of RA in People With RA & Receiving MethotrexateCOMPLETEDPHASE22002-042004-052004-05
NCT00111774Evaluating ABX-EGF in Patients With Metastatic ColorectalCarcinomaCOMPLETEDPHASE22002-03
NCT00527215Phase 2 Study of Darbepoetin Alfa Extended DosingCOMPLETEDPHASE22002-032003-102003-10
NCT00035594Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving ChemotherapyCOMPLETEDPHASE32002-022004-062004-02
NCT00369772STAAR-1 Clinical StudyCOMPLETEDPHASE42002-022004-05
NCT00527267Safety and Efficacy Study of AMG 073 in Hemodialysis SubjectsCOMPLETEDPHASE32002-022003-042003-04
NCT00368901STAAR-2 Clinical StudyCOMPLETEDPHASE42002-012004-052004-03
NCT00038064Anemia in Patients With a Non-Myeloid MalignancyCOMPLETEDPHASE32002-012004-042003-10
NCT00034346ABX-EGF in Combination With Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)COMPLETEDPHASE22002-01
NCT00037635A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Dialysis PatientsCOMPLETEDPHASE32001-122003-032003-03
NCT00035607Chemotherapy Related AnemiaCOMPLETEDPHASE22001-122003-042002-12
NCT0052708512-month Study of AMG 073 in Renal OsteodystrophyCOMPLETEDPHASE22001-102003-082003-08
NCT00540696Study to Develop a Screening Tool for Functional Capacity in Anemic Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Darbepoetin AlfaCOMPLETEDPHASE22001-092003-092003-06
NCT00537667The SPECTRA StudyTERMINATEDPHASE22001-082003-062003-03
NCT00078806Safety and Efficacy Study of Etanercept (Enbrel®) In Children With Systemic Onset Juvenile Rheumatoid ArthritisTERMINATEDPHASE32001-06-042004-05-062004-05-06
NCT00037700Evaluation of the Efficacy of Combination Treatment With Anakinra and Pegsunercept in Improving Rheumatoid ArthritisCOMPLETEDPHASE22001-052002-12
NCT00037518A Study of an Investigational Medication for Severe Primary Hyperparathyroidism or Parathyroid CancerCOMPLETEDPHASE42001-04
NCT00936988A Multicenter, Open-label Extension Study to Assess the Long-term Safety and Efficacy of an Oral Calcimimetic Agent AMG 073 (Cinacalcet) in Primary HyperparathyroidismCOMPLETEDPHASE22000-112005-122005-06
NCT03781375Etanercept Plus Methotrexate Versus Methotrexate Alone in Children With Polyarticular Course Juvenile Rheumatoid ArthritisTERMINATEDPHASE32000-08-242002-06-242002-06-20
NCT00527137NESP Pediatric StudyCOMPLETEDPHASE32000-082004-112004-11
NCT00037648Juvenile Rheumatoid ArthritisCOMPLETEDPHASE22000-072003-112003-11
NCT03776058Safety, Tolerability, and Clinical Effects of Twice-daily Doses of Cinacalcet (AMG 073) in Adults With Primary Hyperparathyroidism (HPT)COMPLETEDPHASE22000-06-152000-12-262000-12-26
NCT00526929Fixed Dose NESP Study in Subjects With CRICOMPLETEDPHASE22000-052002-022002-02
NCT00132418Study of Enbrel in Rheumatoid Arthritis (RA) Subjects With Comorbid DisordersCOMPLETEDPHASE42000-042004-022004-02
NCT00317499Double-blind, Randomized, Placebo-controlled Phase 3 Study of Etanercept in the Treatment of Psoriatic Arthritis and PsoriasisCOMPLETEDPHASE32000-042002-072002-06
NCT00035620Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving ChemotherapyCOMPLETEDPHASE22000-042007-042007-01
NCT00936650A Study to Assess the Efficacy and Safety of Twice-Daily Dose Regimens of an Oral Calcimimetic Agent AMG 073 (Cinacalcet) in Primary Hyperparathyroidism (PHPT)COMPLETEDPHASE21999-112001-062001-03
NCT03776032A Novel Erythropoiesis Stimulating Protein (NESP; Darbopoetin Alfa) for the Treatment of Anemia in Lung Cancer Patients Receiving Multi-cycle Platinum-Containing ChemotherapyCOMPLETEDPHASE31999-09-142002-02-272000-11-08
NCT00540384Dose-finding Study of Novel Erythropoiesis Stimulating Protein (NESP) for the Treatment of Anaemia in Subjects With Solid Tumours Receiving Multicycle ChemotherapyCOMPLETEDPHASE1, PHASE21999-072002-062002-03
NCT00356590Open-Label Extension Treatment With Etanercept (TNFR:Fc) for Participating Patients in Etanercept (TNFR:Fc) Clinical Trial 016.0012COMPLETEDPHASE31998-122009-042008-12
NCT03774771Safety, Pharmacokinetics, and Clinical Effects of Cinacalcet (AMG 073) in Primary HyperparathyroidismCOMPLETEDPHASE21998-09-291999-12-131999-12-13
NCT03780959Safety and Efficacy of Etanercept (Recombinant Human Tumor Necrosis Factor Receptor Fusion Protein [TNFR:Fc]) in Children With Juvenile Rheumatoid Arthritis (JRA)COMPLETEDPHASE2, PHASE31997-05-011998-07-081998-07-08
NCT00357903Open-Label Extension Treatment With Etanercept (TNFR:Fc) for Participating Patients in Etanercept (TNFR:Fc) Clinical TrialsCOMPLETEDPHASE31997-042009-042008-12
NCT00111410Evaluating the Effect of Anakinra (r-metHuIL-1ra) on Vaccine AntibodyResponse in Subjects With Rheumatoid Arthritis (RA)COMPLETEDPHASE42003-11
NCT00111462Evaluating Treatment of Anemia in Subjects With Non-Myeloid MalignanciesReceiving Multicycle ChemotherapyCOMPLETEDPHASE2
NCT00113958Cinacalcet Study to Reach Kidney Disease Outcomes Quality Initiative (K/DOQI) LevelsCOMPLETEDPHASE2
NCT00148421Study for the Treatment of Anemia in Patients With Non-myeloid Malignancies Receiving Multicycle Chemotherapy.COMPLETEDPHASE3
NCT00041665Recombinant Human Keratinocyte Growth Factor to Reduce Oral Mucositis in Hematologic Malignancy Patients Undergoing Peripheral Blood Stem Cell Transplantation After Radiation and High-dose ChemotherapyCOMPLETEDPHASE3
NCT00111124Enbrel® in Psoriatic ArthritisCOMPLETEDPHASE4
NCT00110903Treatment for Subjects With Active Rheumatoid Arthritis (RA)COMPLETEDPHASE3
NCT00117065Study of Transplant Related Anemia Treated With Aranesp® (STRATA)COMPLETEDPHASE4
NCT00117130Study to Evaluate Effectiveness of Aranesp®COMPLETEDPHASE4
NCT00113776Evaluating ABX-EGF Extended Therapy in Subjects With MetastaticColorectal CancerCOMPLETEDPHASE2
NCT00102830Study Evaluating AMG 386 in Adult Patients With Advanced Solid TumorsCOMPLETEDPHASE1
NCT00124111A Study of Cyclophosphamide/Methotrexate/5-Fluorouracil (CMF) With Pegfilgrastim in Subjects With Breast CancerCOMPLETEDPHASE2
NCT00117104Evaluating Aranesp® in Subjects With End Stage Renal Disease onChronic HemodialysisCOMPLETEDPHASE4
NCT00119600A Study of AMG 114 Administered by Subcutaneous Injection for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies Receiving Multicycle ChemotherapyTERMINATEDPHASE1, PHASE2
NCT00036023Chemotherapy Related Anemia in Patients With Non-Myeloid MalignanciesCOMPLETEDPHASE2
NCT00111111An Evaluation of Etanercept in the Treatment of Subjects With PsoriasisCOMPLETEDPHASE3
NCT00117078Aranesp® Monthly Preference Study - 2COMPLETEDPHASE4
NCT00115414Same Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy (TAC)COMPLETEDPHASE2
NCT00124098An Evaluation of Aranesp® in Subjects With Anaemic Chronic Kidney Disease (CKD)COMPLETEDPHASE3
NCT00117455A Study of Peripheral Blood Progenitor Cell (PBPC) Mobilisation by Chemotherapy With Pegfilgrastim or Filgrastim in Subjects With Non-Hodgkin's LymphomaCOMPLETEDPHASE2
NCT00121043Evaluating Kineret® (Anakinra) in Rheumatoid Arthritis (RA) Subjects Using aSelf-Reported QuestionnaireCOMPLETEDPHASE4
NCT00044902Monoclonal Antibody Treatment for Non-Hodgkin's Lymphoma (Low-Grade)COMPLETEDPHASE2
NCT00117091Anakinra (Kineret®) in Combination With Disease Modifying Anti-Rheumatic Drugs (DMARDS) in Subjects With Active Rheumatoid Arthritis (RA)COMPLETEDPHASE3
NCT00002433The Effects of r-metHuIFN-Gamma on the Lungs of Patients With AIDSCOMPLETEDNA
NCT00002126A Randomized, Controlled, Multicenter Trial of Filgrastim (Recombinant-Methionyl Human Granulocyte Colony Stimulating Factor; G-CSF) for the Prevention of Grade 4 Neutropenia in Patients With HIV Infection.COMPLETEDPHASE2
NCT00002037Evaluation of the Therapeutic Benefit of r-metHuIFN- Gamma in AIDS Patients With Disseminated Mycobacterium Avium-Intracellulare (MAI) Infection: A Multi-Centered Pilot StudyCOMPLETEDNA
NCT00002255An Open-Label Phase I/II Study of Recombinant Granulocyte Colony Stimulating Factor (r-metHuG-CSF) and Recombinant Erythropoietin (rHuEPO) Given Subcutaneously Along With Zidovudine (AZT) to Patients With the Acquired Immune Deficiency Syndrome (AIDS) or Severe AIDS-Related Complex (ARC)COMPLETEDPHASE1
NCT00002281A Study of Granulocyte Colony-Stimulating Factor Plus Recombinant Erythropoietin Plus Zidovudine in Patients With AIDS or AIDS-Related ComplexCOMPLETEDNA